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Acute lung injury is implicated in many respiratory diseases, including lung
adenocarcinoma and emphysema. In this thesis, the hypothesis that the stress protein
p53 is important in acute lung injury was investigated. p53 is a short-lived, latent
transcription factor which is activated and stabilised in response to a wide range of
cellular stresses, including DNA damage. In certain cell types, wild type p53 protein
mediates a variety of DNA damage responses and transcriptionally modulates a
battery of downstream genes involved in DNA repair, growth control, and apoptosis.
The effects of p53 were investigated in a mouse model of acute lung injury and in
short-term primary cultures of isolated Clara cells. Gene targeted mice, germline
deficient in p53, were exposed to y-irradiation and compared to wild type controls.
The in vivo response to DNA damage was characterised in terms of growth arrest,
apoptosis, morphology, and gene expression. An acute stress response was observed
in vivo, and localised to a subpopulation of the lung epithelium, the bronchiolar cells.
p53 was stabilised in this population and was associated with transcriptional
induction of Bax, but not other bcl-2 family members. p53 deficient mice did not
display this rapid accumulation of Bax transcripts, as assessed by RNase Protection
Assay. Within wild type and p53 null mice, y-irradiation did not induce apoptosis in
lung epithelial cells at any timepoints studied, as assessed by morphology, but did
induce strand breaks that were detectable by TUNEL. Cell cycle activity, as assessed
by BrdU incorporation, was infrequent in the lung at all timepoints, regardless of p53
status, and hence an effect of p53 on cell cycle progression was not detected in vivo.
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The effects of p53-deficiency were additionally investigated in short-term primary
cultures of murine bronchiolar Clara cells. Culturing of Clara cells allowed an
assessment of the functional consequences of p53 deficiency in proliferating cells.
Clara cells, isolated from gene-targeted p53-deficient mice, were compared to cells
derived from wild type littermates. Baseline proliferation rates, as determined by
BrdU incorporation, were similar irrespective of p53 status. p53 null cultures
displayed abnormal morphology; specifically, a high incidence of multinucleation,
which increased with time in culture. Multinucleated cells maintained expression of
the Clara cell marker CC10, and were proficient in S phase DNA synthesis, as
determined by BrdU incorporation. Nucleation defects in p53 -/- Clara cells
associated with abnormalities in mitosis and cytokinesis, as documented by time-
lapse videomicroscopy, and with increased centrosome number, determined by
confocal microscopy. Defects in centrosome homeostasis, mitotic fidelity, and
cytokinesis in p53-null Clara cells may reflect a novel role of p53 in preserving
genomic integrity in lung epithelium.
Effects of p53-deficiency were also studied following exposure to DNA damage. A
p53-dependent reduction in the BrdU index was observed in Clara cells following
ionizing radiation. The reduction in BrdU index in wild type cells displayed serum-
dependency, and occurred only in the absence of serum. Apoptosis was infrequent in
both genotypes, as determined by time-lapse videomicroscopy. Taken together,
these findings demonstrate that in murine primary Clara cell culture, growth arrest
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but not apoptosis is a p53-mediated response to DNA damage, and that extracellular
factors, such as serum, influence this response.
In addition, a transgenic model employing lung-specific Cre/lox technology was
evaluated. The Cre/lox recombinase system evolved within bacteriophage PI as a
mechanism to maintain correct unit copy segregation of the prophage within host
cells. This thesis reports application of this system to regulate gene expression in
murine lung epithelial cells in vivo, with the eventual goal of generating improved
mouse models of acute lung injury. Transgenic mice expressing Cre from the lung-
specific promoter human SP-C were crossed to a Floxed DNA Ligase I line, and
transgene stability and function assessed by PCR and Southern blot methodologies.
The SP-C Cre transgene was demonstrated as stable, but of low copy-number.
Excision of the floxed allele, as determined by PCR, was specific to the lung, and
was not observed in other tissues. However, the level of excision was poor as
assessed by Southern analysis of the excision event. Furthermore, Cre expression
was undetectable by RT-PCR. Low expression levels of Cre may reflect the low
copy-number of the SP-C/Cre transgene.
In summary, this thesis reports on the role of p53 in lung epithelial cells, and on the
feasibility of using Cre/lox technologies to regulate gene expression in the lung
epithelium of transgenic mice. Bax mRNA induction, but not apoptosis, is a DNA
damage response of small airway epithelial cells. Transactivation of Bax was p53-
dependent in irradiated lung, as determined by RNase protection assay, and did not
occur in p53-/- mice. To further investigate the role of p53 in the lung, a method for
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extracting, isolating, and culturing Clara cells, a progenitor cell of the lung, was
established and incorporated into this analysis. Absence of p53 favours
multinucleation and loss of cell cycle arrest in primary Clara cell culture, and
highlight additional roles of p53 in cell division and growth control. In addition, this
thesis explored the feasibility of using Cre/lox technologies to regulate gene
expression in murine lung epithelium. SP-C/Cre mice were assessed in their ability
to excise a Floxed DNA Ligase I cassette in the tissues of double transgenic mice.
Cre-mediated excision was specific to lung epithelium, but infrequent.
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1. Introduction
1.1. BIOLOGY OF SMALL AIRWAY EPITHELIUM
l.l.a. THE BRONCHIOLE
At least eight principal types of epithelial cells have been identified in the linings of
the tracheobronchial conducting airways in mammals (reviewed in Harkema et al.,
1991). Four of these cell types - mucous goblet cells, serous cells, small mucous
granule cells, and basal cells - are restricted anatomically to the proximal airways
and will be discussed no further. The remaining four cell types - the ciliated cell, the
neuroendocrine cell, the brush cell, and the Clara cell - are often found in both the
proximal and distal conducting airways of mammals, although with marked
interspecies differences in distribution. The behaviour of these cell types is integral
to our understanding of bronchiolar physiology, and their biology is summarised
below (see Figure 1.1.i).
l.l.a.l. Ciliated cells
The ciliated cell engenders mucous flow towards the tracheobronchial escalator, a
function generated by the numerous motile cilia that line the luminal surface,
facilitating pulmonary clearance of particulates, dead cells and excess surfactant.
The cilium is composed of a set of characteristic tubules the structures and
arrangement of which vary over its length. Long microvilli are interspersed among
the cilia along the apical surface of the cell. The numerous microvilli and cilia
5
o
O O Clara Cell Secretions
0
Neuroendocrine Cell
Figure 1.1.i. A model describing the cellular constituents of the bronchioli. The
bronchioli consist of multiple cell types, including ciliated cells, Clara cells, and
neuroendocrine cells. Ciliated cells engender mucous flow towards the bronchi, and
thus facilitate pulmonary clearance. Clara cells secrete surfactant, which assist in
alveolar integrity and pulmonary clearance. Clara cells additionally serve as
progenitor cells of the bronchioles, and differentiate into ciliated cells as required.
Neuroendocrine cells are occasionally observed in the bronchioli. It is suspected that
neuroendocrine cells participate in remodelling of the conducting airways.
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provide the cell with added luminal surface area that may additionally be important
for ion exchange between the extracellular airway fluid and the intracellular
cytoplasm (Harkema et ah, 1991).
Ciliated cells are the prominent cell type in the bronchi and bronchioles, but are
particularly susceptible to injury from inhaled irritants (Harkema et ah, 1987; Nikula
et ah, 1988). Ciliated cells are terminally differentiated cells, and regeneration of
denuded epithelium, a consequence of irritant exposure, is dependent on the
recruitment of Clara cells (Plopper & Dungworth, 1987).
1.1.a.2. Neuroendocrine ceils
Neuroendocrine cells are rare in the airway epithelium of most species (Harkema et
ah, 1991). When present, they usually lie in a basal position, but may have a
cytoplasmic projection to the airway surface. These cells can occur individually or
as clusters of cells, termed neuroepithelial bodies, and are thinly scattered at the
laryngotracheal junction and at bifurcations of intrapulmonary bronchi (Terzakis et
ah, 1972; Sorokin et ah, 1983). The presence of these cells increases from the main
bronchi to the bronchioli, but neuroendocrine cells are infrequently found in terminal
bronchioli (Tateishi, 1973).
Numbers of neuroendocrine cells are thought to be increased in chronic lung diseases
such as bronchopulmonary dysplasia, cystic fibrosis, and asthma (Aguayo, 1993;
Gosney et ah, 1989; Johnson et ah, 1993). Extended exposure to a variety of
pollutants such as tobacco smoke (Sunday et ah, 1988), nitrosamines (Linnoila,
7
1982), and napthalene (Peake et al., 2000) results in neuroepithelial body cell
hyperplasia. Neuroepithelial body hyperplasia occurs principally at airway branch
points and, by virtue of their association with proliferating Clara cells, a role in
remodelling of the conducting airways has been suggested (Reynolds et al., 2000).
l.l.a.3. Brush cells
Brush cells have been identified in the conducting airways of a number of species
and are present along the full length of the respiratory airway (Harkema et al., 1991).
Their name is derived from the brush border of closely packed microvilli that coats
their apical surface. They are present infrequently, making up fewer than 1% of the
total cell population. However, their presence has not been demonstrated
convincingly in humans (Harkema et al., 1991). The function of the brush cell is
unknown, but roles in absorption of periciliary fluid, chemoreception, and
ciliogenesis have been suggested (Jeffery, 1987). Lack of brush cells in human
columnar epithelium dictates that their contribution to small airway disease is
improbable.
1.1.a.4. Clara cells
Clara cells express Surfactant proteins SP-A, B, and D, which are secreted into the
lumen and assist in alveolar integrity (reviewed in Plopper et al., 1997), and a
secretory protein homologous to uteroglobin with similar antiinflammatory
properties (Gupta et al., 1987; Gupta & Hook, 1988; Lopez de Haro et al., 1988;
Singh et al., 1988; Johnston et al., 1999). This secreted protein, Clara cell lOkDa
protein (CC10), is expressed specifically in Clara cells and is frequently used as a
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cell marker (Boers et al., 1999; McBride et al., 2000). Clara cells additionally
express Cytochrome P450 isoenzymes, the nature of which vary between species
(Plopper et al., 1997; Harkema et al., 1991). The pattern of P450 isoenzyme
expression accounts for Clara cell sensitivity to certain aromatic hydrocarbons, such
as napthalene.
The observation that ciliated cells develop from Clara cells (Plopper & Dungworth,
1987; Evans et al., 1976; Brody et al., 1987; Hook et al., 1987) revived an interest in
the Clara cell as a potential stem cell in the airways. The distal migration of Clara
cells in the lungs of animals exposed to ozone, and the frequent 'bronchiolisation' of
alveoli in lungs with chronic injury further suggest a role of the Clara cell in alveolar
remodelling. However, it is noteworthy that Clara cells display marked interspecific
heterogeneity in their distribution (Plopper et al., 1980a,b,c; Widdicombe & Pack,
1982). Significantly, in rodents Clara cells occupy tracheal, bronchial, and
bronchiolar epithelium, whereas primates accommodate Clara cells in only the
epithelium lining terminal and respiratory bronchioles (Harkema et al., 1991; Boers
et al., 1999). It is suggested that adenocarcinoma of the lung, a tumour of the small
airways, represents malignancy of the Clara cell (see section 1.2.c). Consequently,
there is great interest in the effects of xenobiotics and other DNA-damaging agents
on Clara cells.
Clara cell isolation and enrichment, a procedure involving dissociation of airway
epithelia and separation of cell types by density and differential attachment, has been
used to investigate key features of Clara cell physiology including xenobiotic
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transformation and lectin binding patterns (Murphy et al., 1999; McBride et al.,
2000). Short term primary Clara cell cultures from the mouse can be maintained for
up to 5 days in serum-free medium, and represent a powerful tool for assessing the
effects of gene deficiency in lung epithelial cells.
1.1.b. THE ALVEOLUS
The alveolus is the quintessential compartment of the lung and is the principal site of
gas exchange (see Figure l.lii). Gas exchange is accomplished over the respiratory
membrane, where epithelium is separated from endothelium by, in health, only a thin
interstitium. Thickening of the alveolar interstitium is a common response to inhaled
irritants and induces respiratory distress via loss of the surface area over which gas
exchange can take place. Alveolar epithelium is composed of two cell types, named
the Type I and Type II cell.
1.1.2.1. Type I cells
Type I cells are flattened, highly branched squamous cells, and are the principal cell
type associated with gas exchange (reviewed in Harkema et al., 1991). Massive
surface area to volume ratio of these thread-like cells enables efficient gas exchange
between the capillary endothelium and the alveolar lumen. Type I cells are
particularly susceptible to damage by inhaled pollutants, but are regenerated from













Figure 1.1.ii. A model describing the cellular constituents of the alveoli. The alveoli
consist of multiple cell types, including Type and Type II epithelial cells, endothelial
cells, fibroblasts and macrophages. Gas exchange is accomplished over the
respiratory membrane, where Type I cells are juxtaposed to endothelial cells with
only a thin interstitium in between. Type II cells assist in alveolar integrity via
secretion of surfactant. Fibroblasts are occasionally observed in the alveoli,
scattered throughout the interstitium. Alveolar macrophages reside in the alveolar
lumen, where they assist in pulmonary clearance of irritants and infectious particles.
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1.1.2.2. Type II cells
Type II cells are the progenitor species of the alveolus and differentiate into Type I
cells as required (reviewed in Plopper et ah, 1997). Type II cells comprise about
15% of the cells in the distal lung, but because of their cuboidal shape they account
for only 10% of the alveolar surface. Type II cells additionally express surfactant
proteins and P450 enzymes, and thus show some similarities with Clara cells. In
addition, a role of type II cells in the transepithelial transport of sodium, a process
that minimises alveolar fluid, has been reported (Harkema et ah, 1991). To date,
type II cells have been isolated from rabbit (Devereux & Fouts, 1981; Finkelstein et
ah, 1983), rat (Mason et ah, 1977; Mason, 1982; Richards et ah, 1987), hamster
(Murphy et ah, 1999), guinea pig (Sikpi et ah, 1986), pig (Murphy et ah, 1999), and
human (Robinson et ah, 1984; Devereux et ah, 1986), but not mouse lungs which
require ex vivo expansion from foetal explants (Glasser et ah, 1991; Shannon, 1994).
The major uses of freshly isolated type II cells are for studies of metabolism (Mason,
1978; Devereux, 1984; Devereux et ah, 1986; Geppert & Elstein, 1983; Maniscalco
et ah, 1983) and injury response (Freeman et ah, 1986; van Klaveren et ah, 1997a,b;
Planus et ah, 1999; Piotrowski et ah, 2000). The relative difficulty in culturing type
II cells from adult mice has hindered genetic dissection of the injury response
pathways specific to this cell type.
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1.2. DISEASE OF THE SMALL AIRWAYS
The small airways are a frequent site of injury to inhaled irritants and infectious
particles. In certain pathologies, such as the infectious pneumonias, the aetiological
agent is known and its contribution to disease understood. In other pathologies,
including ARDS, CFA, lung cancer, and emphysema, DNA damage has been
proffered as a significant factor in the aetiology of the disease.
1.2.a. ARDS
Acute Respiratory Distress Syndrome (ARDS) first became recognised as a major
clinical phenomenon during the Vietnam War (Ashbaugh et al., 1967). An
unconventional way of killing people with conventional weapons, ARDS was
primarily recognised as a common response to smoke inhalation and, later, to
reactive oxygen species in general. ARDS is additionally a complication of sepsis.
ARDS is a common response to high dose ionizing radiation, hyperoxia, and
chemotherapeutics such as bleomycin (reviewed in Canonico & Brigham, 1997).
Insidious oxidative species generated by exposure to these agents activate an
inappropriate vascular response, culminating in thickening of the alveolar
interstitium and destruction of the respiratory membrane. Mutant mice deficient in
antioxidant enzymes, such as Extracellular Superoxide Dismutase (Carlsson et al.,
1995), are particularly susceptible to ARDS and display reduction in survival time
and an earlier onset of oedema. ARDS is additionally a feature of sepsis, and can be
induced by intratracheal or intravenous administration of lipopolysaccharide (LPS)
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or tumour necrosis factor-a (TNF-a) (Murakami et al., 2000; Burdon et al., 2000).
ICAM-1 induction in the pulmonary vasculature, which is TNF-a dependent, is
considered a necessary event in the aetiology of the disease (Sato et al., 2000; Welty
et al., 1997). In addition, Migration Inhibitory Factor (MIF), secreted by alveolar
macrophages, has been identified as a critical determinant in the development of
ARDS (Donnelly et al., 1997). MIF is observed in the alveolar airspaces of patients
with ARDS and augments proinflammatory cytokine secretion and glucocorticoid
responses in the small airways. The authors suggest that MIF may act as a mediator
sustaining the pulmonary inflammatory responses in ARDS (Donnelly et al., 1997).
The latter analysis highlights the importance of the alveolar macrophage in the
aetiology of ARDS.
DNA damage has been observed in alveolar epithelium of ARDS in both humans and
mice, and is associated with p53 induction (Guinee et al., 1996; O'Reilly et al., 1998;
Okudela et al., 1999). Given the importance of p53 in DNA damage responses in
other cell types, it is plausible that p53 may additionally contribute to the aetiology
of ARDS. However, mice germline deficient in p53 are equally susceptible to the
oedematous changes characteristic of ARDS (Santana et al., 1996; see 1.5.b). Thus,
although p53 is induced in ARDS, this implies no causal role of p53 in disease
aetiology. It is probable that p53 induction in the latter syndrome reflects genotoxic
damage, a direct consequence of exposure to reactive oxygen species (see 1.3.a.2).
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1.2.b. Cryptogenic Fibrosing Alveolitis
An alternative outcome to bleomycin and radiation-induced pneumonitis is the
organisation condition Cryptogenic Fibrosing Alveolitis (CFA), also known as
Idiopathic Pulmonary Fibrosis (IPF). CFA is a progressive illness recognisable
histologically by thickening of the alveolar walls and collagen deposition, and
immunochemically by inappropriate cytokine expression (Rube et al., 2000; Hong et
ah, 1999; Buttner et al., 1997). Animal models of CFA have been developed by
exposure to ROS (Franko et al., 1991; Haston & Travis, 1997; Piguet et al., 1997),
and by intratracheal instillation of the fluorescent hapten FITC (Roberts et al., 1995).
In the latter analysis, fibrotic lesions developed principally at sites of hapten
deposition, highlighting local effects of toxic particulates.
CFA is observed infrequently in immunodeficient SCID and nude mice (Roberts et
al., 1995; Schrier et al., 1983; Szapiel et al., 1979), thus appears to be at least
partially dependent on the presence of T and/or B lymphocytes. High levels of TNF-
a and IFN-y segregate with fibrosis in bleomycin-treated animals, and suggest a role
for inappropriate cytokine responses in the induction of fibrosis (Helene et al., 1999).
Furthermore, transgenic mice overexpressing the proinflammatory cytokines TGF-a,
TNF-a, and PDGF display pulmonary fibrosis from an early age (Korfhagen et al.,
1994; Miyazaki et al., 1995; Hoyle et al., 1999). The tissue remodelling
characteristic of CFA is thus unlikely to represent a response to DNA damage, but
rather inflammatory and fibrotic sequelae induced by inappropriate leukocyte
activation. Importantly, CFA can be induced independently of p53 as it is observed
following bleomycin and ionizing radiation-treatment in p53-null mice in a manner
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indistinguishable from wild type littermates (Okudela et al., 1999; Santana et al.,
1996).
1.2.c. Lung Cancer
Lung cancer is a major health problem worldwide due to its high frequency,
especially in developed countries, and accounts for over a million deaths, annually
(reviewed in Hecht, 1999). Cigarette smoking is responsible for 90% of lung
carcinoma in men, and 75-80% in women, and there is epidemiological evidence for
a dose-response relationship with the duration and amount of smoking. Due to the
advanced stage of malignancy at which it is often first diagnosed, lung cancer in
humans is often difficult to treat and exhibits an extremely high mortality rate
(Aisner et al., 1996; Hecht, 1999). Consequently, there is increasing interest in the
normal molecular mechanisms that prevent lung tumourigenesis, which allow for
improved definitions of carcinogenesis, improved patient diagnosis, and offer novel
sites of therapeutic intervention.
Lung cancer is the result of a sequential accumulation of multiple genetic alterations
involving key genes involved in growth control and apoptosis. The malignant
transformation of lung epithelial cells involves mutational/dysregulational activation
of oncogenes, including Ki-ras, c-Myc, C-erb-B2, and mutational inactivation of
tumour suppresor proteins, such as p53 and Rb (Table 1.2). Inactivation of tumour
suppressor genes removes important regulatory constraints on the cell cycle, and is
considered a necessary feature of lung tumorigenesis. Smoking induces a range of
lung carcinomas in humans, and is associated with the development of squamous,
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Table 1.2. - Molecular and Genetic Abnormalities in Lung Cancer










30 Slebos & Rodenhuis, 1992;
Mitsudomi et al., 1991;
Rodenhuis et al., 1988
30-60 Stefanaki et al., 1998;








p53 LOH + mutation 80-100




25-35 Salgia & Skarin, 1998;
Volm et al., 1992;
Kern et al., 1990
10-50 Prins et al., 1993;
Volm et al., 1992;
Kiefer et al., 1987;
Wong et al., 1986
50-80 Sameshima et al., 1992;
Takahashi et al., 1989
20-30 Mori et al., 1990;
Harbour et al., 1988
60 Okamoto et al., 1995;
Kamb et al., 1994
HD, homozygous deletion; LOH, loss of heterozygousity; SCLC, small cell lung carcinoma; NSCLC,
non-small cell lung carcinoma
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neuroendocrine, and non-small cell lung carcinomas (Hecht, 1999; Aisner et al.,
1996). The term adenocarcinoma is used to define a subsection of non-small cell
lung carcinomas defined histologically by the presence of secretory vesicles,
glandular differentiation, and/or mucin production (Travis et ah, 1999). Lung
adenocarcinomas can be experimentally induced in animals by treatment with
tobacco carcinogens (reviewed in Hecht, 1999). Consequently, rodent lung
adenocarcinoma is considered a model of human lung carcinogenesis. Spontaneous
lung adenocarcinomas are observed in certain strains of mice, notably the A/J strain,
and highlight the effect of genetic background on lung tumourigenesis (Wattenberg,
1999; Moody et ah, 2000; Wardlaw et ah, 2000). Spontaneous lung
adenocarcinomas are additionally a feature of p53-mutant mice and humans, the
significance of which is discussed in later chapters (see 1,5.b and 4.2).
Lung adenocarcinoma proceeds through a series of defined morphological stages,
from atypical adenomatous hyperplasia (AAH), through carcinoma in situ
(adenoma), to overt carcinoma (adenocarcinoma) (Kitamura et al 1995; 1996).
Metastases of lung adenocarcinoma are often observed in brain, liver and gut (Aisner
et al., 1996). Malignant transformation of lung epithelial cells involves mutation
and/or dysregulation of key oncogenes and tumour suppressor genes. Mutations in
Ki-ras, Rb and p53 are early events in lung adenocarcinoma, and may highlight
critical steps in lung tumourigenesis (Rodenhuis et al., 1988; Harbour et al., 1988;
Takahashi et al., 1989; Mori et al., 1990; Mitsudomi et ah, 1991; Sameshima et al.,
1992; Slebos & Rodenhuis, 1992). In this respect, the effects of combined p53 and
Rb deficiency have been investigated in the lungs of transgenic mice. SV40 T
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antigen inhibits both p53 and Rb signalling, and induces adenocarcinoma formation
in transgenic mice when expressed from the human SP-C promoter (Wikenheiser et
al., 1992). The human SP-C promoter directs ectopic gene expression in the distal
portion of the developing lung, and in both Clara cells and type II cells of adult
transgenic mice. It is suggested that lung adenocarcinoma of SP-C/SV40 T antigen
mice represents malignancy of the Clara cell (Wikenheiser et al., 1992).
Notwithstanding this, early-stage tumours of these mice frequently express Clara cell
markers in vivo. However, it is noteworthy that in late-stage adenomas of SP-
C/SV40 T antigen mice, expression of Clara cell markers is often lost. By contrast,
type II cell markers are observed in late-stage adenomas and in cell lines established
from SP-C/SV40 T antigen mice. Thus in both tumours and cell lines there is a
blurring of the distinction between Clara and type II cells, a phenomenon which the
authors suggest may reflect altered differentiation of the advancing neoplasms
(Wikenheiser et al., 1992).
1.2.d. COPD and Emphysema
Several terms historically have been used to designate the group of conditions
recognised by obstruction to airflow. Chronic obstructive pulmonary disease
(COPD) is a clinical term denoting a group of diseases "characterised by persistent
slowing of airflow during expiration" (Calverley & Pride, 1995). Thus, the term is a
clinical rather than a pathological diagnosis, and embraces both chronic bronchitis
and emphysema, which often develop together, as the underlying cause of disease.
Emphysema is one pathological correlate of COPD and is an alternative outcome of
life-long tobacco smoking. Defined pathologically as the distension of alveolar
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airspaces and destruction of alveolar walls, emphysema is a progressive disease
which induces respiratory distress via loss of the surface area/volume ratio over
which gas exchange is accomplished. Two major patterns of emphysema - panacinar
and centriacinar - are prevalent in the human species (Figure 1.2). Panacinar
emphysema is an inherited recessive disorder in humans, and is primarily associated
with germline disruption of the alpha-1-antitrypsin gene. Humans and mice
displaying alpha-1-antitrypsin deficiency develop spontaneous panacinar emphysema
from an early age, and are additionally prone to cirrhosis of the liver. Panacinar
emphysema is additionally a feature of the spontaneous mutant mouse strains beige
(Keil et al., 1996), tight-skin (Kielty et al., 1998), blotchy (Fisk & Kuhn, 1976), and
pallid (Keil et al., 1996), each strain incorporating mutations in single distinct genetic
loci. Consequently, panacinar emphysema is a polygenic disease associated with
disturbances in extracellular matrix metabolism. Panacinar emphysema can be
induced experimentally by intratracheal instillation of elastolytic enzymes, including
papain, pancreatic elastase, neutrophil elastase, and proteinase 3 (Gross et al, 1965;
Snider et al., 1986). Airspace enlargement is additionally a feature of transgenic
mice overexpressing collagenase, interleukin-11, or PDGF-B specifically in lung
epithelium (D'Armiento et al., 1992; Ray et al., 1997; Hoyle et al., 1999).
Importantly, panacinar emphysema is not induced in experimental animals by non-
elastolytic proteolytic enzymes, such as bacterial collagenase (Shapiro, 2000).
Centrilobular emphysema is the dominant form of the disease in humans, is
principally associated with life-long tobacco smoking, but is an additional feature of
occupational exposure to cadmium, asbestos, silica, and coal dust. Centrilobular
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Bronchioli are increased in
diameter in centriacinar
emphysema
Enlarged airspaces are a







Figure 1.2. A model describing patterns of emphysema. Centriacinar
emphysema is characterised by enlarged airspaces, and typically involves
respiratory bronchioles. Panacinar emphysema involves the entire acinus, or
more commonly entire lobules (panlobular), but is not localised to the
centriacinus.
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emphysema is characterised grossly by enlarged airspaces, generally measuring from
1 to 10mm in diameter, surrounded by normal lung tissue (Calverley and Pride,
1995). A typical centrilobular lesion involves respiratory bronchioles, which gives
the lesion a centriacinar location (Figure 1.2). The mechanism by which tobacco
smoke induces emphysema is complex, but with macrophage elastase identified as a
candidate intermediate. Macrophage elastase (MMP-12) is expressed in human
alveolar macrophages of cigarette smokers and in patients with emphysema, but not
in normal lung tissue (Shapiro, 2000). Knockout mice deficient in MMP-12 mice
have been generated and are resistant to the emphysemous changes typical of chronic
cigarette smoke exposure (Hautakami et ah, 1997). Surprisingly, MMP-12-/- mice
also fail to recruit macrophages into their lungs in response to cigarette smoke
(Hautakami et ah, 1997; Shapiro, 2000). Based on these observations, Shapiro
(2000) suggests a model of human emphysema by which cigarette smoke induces
constitutive macrophages to produce MMP-12, which cleaves elastin, generating
fragments chemotactic for monocytes. A positive feedback loop is generated which
perpetuates macrophage accumulation and concomitant lung destruction. However,
it should be emphasised that these observations do not account for the bronchiolar
enlargement typical of human smoking-related emphysema. Indeed, centriacinar
emphysema is infrequent in experimental animals. Consequently, animal models of
emphysema are interesting, but limited. An alternative strategy is to understand
precise features of injury responses in bronchiolar cells. Methods for culturing
bronchiolar Clara cells from the mouse have been developed and have been used to
discern the role of bronchiolar cells in xenobiotic metabolism. Primary Clara cell
culture technology could additionally be exploited to determine injury responses of
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bronchiolar cells. Understanding the genetic basis of bronchiolar cell injury
responses in vitro may represent a method of addressing the molecular mechanisms
underlying human centriacinar emphysema.
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1.3. DNA DAMAGE AND THE LUNG
1.3.a. Tobacco Smoking and Lung Disease
The literature on the toxic effects of tobacco smoke is huge, hence the following
discussion is brief. Tobacco smoking has proved a most effective method of
delivering toxins to the lung. Extensive epidemiological data establish cigarette
smoking as the major cause of lung cancer, and it is estimated that about 90% of
male lung cancer deaths, and 75-80% of female lung cancer deaths in the United
States each year are caused by smoking (reviewed in Hecht, 1999). The risk of lung
cancer diminishes after smoking cessation, but not during the first five years, and the
relative risk never returns to that of a non-smoker (Hecht, 1999). Chronic
Obstructive Pulmonary Disease, the clinical manifestation of emphysema, is an
additional smoking-related disease, and represents the 4th leading cause of death in
the United States (WHO, 1999). Smoking-related emphysema is characterised
biochemically by protease/antiprotease and oxidant/antioxidant imbalances, and is
considered a consequence of chronic neutrophil and macrophage hyperactivity in the
airways (Shapiro 1999; 2000). DNA damage of brochioalveolar cells is a feature of
smokers (De Flora et al., 1996), and chronic DNA damage may contribute to the
development of smoking-related emphysema.
Tobacco smoke contains a rich source of DNA-damaging agents, which can be




There are 55 carcinogens in tobacco smoke that have been evaluated by the
International Agency for Research on Cancer (IARC) and for which there is
"sufficient evidence for carcinogenicity" (reviewed in Hecht, 1999). Of these, the
polycyclic aromatic hydrocarbon (PAH) benzo[a]pyrene (BaP), and the nitrosamine
4-(methylnitrosoamino)-l-(3-pyridyl)-l-butanone (NNK) are the most extensively
studied. BaP's ability to induce lung tumours upon local administration or inhalation
is well documented (Hecht, 1999; Thyssen et al., 1981; Morse et al., 1995). It is
however noteworthy that when administered systemically, it causes lung tumours in
mice, but not in rats (Hecht, 1999; Culp et al., 1998). The tobacco-specific N-
nitrosamine NNK is a potent lung carcinogen in rats, mice, and hamsters (Hecht,
1998). NNK is organospecific for the lung, and induces adenoma and
adenocarcinoma formation independent of the route of administration (Hecht, 1999).
Tobacco smoke is additionally a tumour promoter, the majority of this activity being
dependent upon uncharacterised weakly acidic compounds (Hecht, 1999).
Substantial levels of cocarcinogens, such as catechol, decane, pyrene, and
benzo[e]pyrene are present in tobacco smoke. In addition, cigarette smoke contains
high levels of acrolein, which is cytotoxic to the pulmonary cilia (Hecht, 1999).
Carcinogens in tobacco smoke are enzymatically transformed to a series of
metabolites as the exposed organism attempts to convert them to forms that are more
readily excreted. The initial steps are usually carried out by the cytochrome P450
(CYP) enzymes, which oxygenate the substrate. Other enzymes, such as
lipoxygenases and cyclooxygenases, may additionally be involved. The oxygenated
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intermediates formed in these initial reactions may undergo further transformation by
glutathione-S-transferases (GST), uridine-5 '-diphosphate-glucuronosyl-transferases,
sulphatases, and other enzymes, a process known as detoxification (Spitz et ah, 1999;
Shields & Harris, 2000). Some of the metabolites produced by the P450s react with
DNA to form covalent adducts, and thus elicit damage requiring excision and
mismatch repair processes. Genes encoding carcinogen-metabolising enzymes, such
as CYP1A1, N-acetyltransferase 2, and GSTM1 are polymorphic within the human
population, and it is thought they may confer both resistance and susceptibility traits
to smoking-related disease (Spitz et ah, 1999; Shields & Harris, 2000).
1.3.a.l.i. 06-methylguanine
Several studies have documented the presence of alkylated guanosine residues,
particularly, 7-methyldeoxyguanosine in the lungs of smokers (Kato et ah, 1993;
Shields et ah, 1990; Mustonen et ah, 1993; Kato et ah, 1995;Blomeke et ah, 1996;
Petruzzelli et ah, 1996). While 7-methylguanine is not generally considered a
miscoding adduct, other methyl adducts which do have miscoding properties, such as
06-methylguanine (06meG), are formed at the same time, but at lower levels (Hecht,
1999). 06meG is a mutagenic and cytotoxic DNA adduct that can be formed in vivo
by such diverse agents as tobacco smoke, methylnitrosurea, and other methylating
agents (Hecht, 1999). In vitro studies (Singer et ah, 1989; Dosanjh et ah, 1993;
Snow et ah, 1984), as well as in vivo mutagenesis assays (Bhanot & Ray, 1986;
Loechler et ah, 1984), have shown that 06meG preferentially base pairs with dTMP
instead of dCMP, thus giving rise to G to A transition mutations. The importance of
these lesions has been demonstrated in vivo. Specifically, a strong correlation was
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found between the persistence of 06meG lesions and tumours in rodents (Goth &
Rajewsky, 1974). Furthermore, the persistence of 06meG lesions after treatment
with 4-(methylnitrosoamino)-l-(3-pyridyl)-l-butanone (a component of tobacco
smoke) has been found to correlate with the activation of the Ki-ras oncogene in lung
tumours in mice (Devereux et ah, 1993).
The 06meG lesion can be readily repaired in a saturable manner by the suicide
enzyme methylguanine-DNA methyltransferase (MGMT) (Pegg, 1990). Repair
occurs via the transfer of the methyl group to a cysteine residue in the MGMT
protein, a process that is stoichiometric and autoinactivating (Margigson &
O'Connor, 1990; Pegg, 1990). This type of repair is error free and noncytotoxic.
However, in many human solid tumour cell lines and in some non-tumour tissues the
ability to repair 06mG is lacking due to a failure to activate MGMT (Zaidi &
O'Connor, 1995; Pegg, 1990; Yarosh et al., 1983, Yarosh et ah, 1984; Day et ah,
1980). In this respect, it is noteworthy that MGMT induction following DNA
damage is p53-dependent in tissues of wild type mice (Rafferty et ah, 1996). The in
vivo consequences of MGMT deficiency are best understood in the lethal response to
chemotherapeutic agents. Knockout mice, germline deficient in MGMT, are 2- to
10-fold more sensitive to the lethal effects of the 06-alkylating agents MNU, BCNU,
and temozolamide than wild type mice (Glassner et ah, 1999), but show similar
sensitivities to cross-linking agents such as cyclophosphamide and mitomycin C
(Shiraishi et ah, 2000; Glassner et ah, 1999). Consequently, MGMT is of critical
importance in protecting against the toxic effects of alkylating agents, such as those
used for cancer chemotherapy. Furthermore, transgenic mice overexpressing MGMT
27
have been generated, and are relatively resistant to NNK-induced lung
tumourigenesis (Liu et al., 1999), documenting tumour suppressor properties of
MGMT, and highlighting a potential protective role of MGMT in tobacco
carcinogenesis. Based on these observations, Hecht (1999) and others (Liu et al.,
1999) speculate that formation of 06-methylguanine lesions is the principle
mutagenic effect of the tobacco-specific nitrosamine NNK.
1.3.a.2. Reactive Oxygen Species
Tobacco smoke additionally contains high concentrations of reactive oxygen species
(ROS), which are strongly implicated in diseases related to smoking, particularly
cancer (Ames, 1983; Church & Pryor, 1985; Pryor, 1987). Free radicals from
tobacco smoke severely deplete the pool of intracellular antioxidants in living cells,
and induce oxidative damage in humans and experimental animals (Leanderson &
Tagesson, 1993). Free radicals can attack DNA bases or deoxyribose residues to
produce damaged bases or strand breaks (Dizdaroglu, 1993). Alternatively, ROS can
oxidise lipid or protein molecules to generate intermediates that react with DNA to
form adducts (Cheeseman, 1993). It is established that superoxide radical, lipid
peroxides and hydrogen peroxide are not sufficiently reactive per se to attack DNA
(Meneghini & Hoffman, 1980; Brawn & Fridovich, 1981; Lesko et al., 1980). It is
instead proposed that relatively stable species, such as hydrogen peroxide and lipid
peroxide, migrate from their generation site and react with nuclear Fe(II) or Cu(I) to
produce hydroxyl radical and alkoxyl radicals in site-specific Fenton reactions
(Mello-Fihlo & Meneghini, 1991) (Figure 1.3). Being generated close to DNA, these
radicals may then induce DNA damage.
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Figure 1.3 - The Fenton Reaction. Hydrogen peroxide (i) and alkylated hydroxides (ii) react
with Fe(II) to generate hydroxyl radical and alkoxyl radical, respectively. It is assumed that
iron ions are bound to DNA and therefore that the Fenton reaction generates hydroxyl/alkoxyl
radicals in situ. Neocurpoine, a copper specific lipophilic chelator which blocks the Cu-
mediated Fenton reaction, does not protect cells from H202, implying that iron, and not copper,
is the metal mediating the damage in most cases (Mello-Fihlo & Meneghini, 1991).
i) H202 + Fe2+ OH* + OH + Fe 3+
ii) ROOH + Fe2+ RO* + OH + Fe 3+
1.3.a.2.i. 8-oxo-dG
Free radicals induce a number of lesions in DNA, including base damage, sugar
damage, strand breaks, cross-links, and the generation of abasic sites (Dizdaroglu,
1993). 8-oxo-dG is not necessarily the most abundant DNA product, nor is it the
most mutagenic, but it has been the most extensively studied because it is the most
easily measured. 8-oxo-dG levels are increased in the lungs of smokers, and can
additionally be detected in the urine. 8-oxo-dG causes miscoding by DNA
polymerase in vitro, and site-specific mutagenic experiments verify that 8-oxo-dG is
mutagenic in mammalian cells. However knockout mice, germline deficient in the
Oggl gene responsible for 8-oxo-dG repair, display increased 8-oxo-dG levels, but
no discernible pathology (Klungland et al., 1999). Consequently, the biological
significance of 8-oxodG damage is not understood.
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1.3.a.2.ii. Double Strand Breaks
Double Strand Breaks (DSBs) induce both chromosomal abnormalities and gene
mutations, and are considered integral to radiation carcinogenesis (Little, 2000).
DSBs are an additional consequence of tobacco smoke exposure in vitro (Leanderson
& Tagesson, 1993). In mammalian cells, DSBs are repaired by homologous and
non-homologous mechanisms (reviewed Karran, 2000). Homologous recombination
(HR) is a highly accurate process which can restore the precise DNA sequence at the
double strand break. Homologous recombination requires extensive regions of
homologous DNA and takes place by means of replication, using information on the
undamaged sister chromatid or homologous chromosome. DSBs are initially
processed by the Mrel 1/Rad50/NSB1 nuclease complex to produce a single-stranded
region with 3'overhang (Karran, 2000). Rad52 has DNA double-strand end binding
activity and protects DNA ends from exonucleases. Interactions between Rad52 and
Rad51 are thought to promote polymerisation of Rad51 onto single-stranded DNA to
form a nuceloprotein filament that searches for the homologous duplex DNA. The
formation of joint molecules between homologous strand of damaged and
undamaged DNA is followed by exchange of DNA strands, which allow for semi-
conservative replication.
In contrast, non-homologous end-joining (NHEJ) is a process in which two broken
strands are joined directly, often resulting in deletions or small insertions.
Characteristically, NHEJ requires no homology with an undamaged DNA partner
and no, or only a few base pairs of sequence homology between the two broken ends.
The process of NHEJ involves the DNA-PK complex, the kinase activity being
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dependent upon binding of Ku70 and Ku80 proteins to the broken DNA ends.
Ku70/Ku80 heterodimers bind to DSBs in a sequence-independent manner and
recruit the catalytic subunit (DNA-PKcs) to the DSB, facilitating interactions
between DNA-PKcs and DNA and stimulating DNA-PKcs kinase activity. DNA-
PKcs recruits and regulates the activities of other protein complexes involved in
NHEJ, including the XRCC4/DNA ligase IV complex required for joining the filled-
in DNA ends, and the RNA polymerase I complex, repression of which facilitates
NHEJ (Kuhn et al., 1995; Labhart, 1995). Most DSBs are repaired by this
illegitimate recombination process, which is error-prone, and thus likely accounts for
many of the potentially mutagenic lesions induced by clastogenic agents. It is further
noteworthy that Ku80 expression has been observed to suppress chromosomal
rearrangements in undamaged murine cells (Difilippantonio et al., 2000),
documenting a housekeeping function of DNA-PK in maintaining genome integrity.
1.3.2. Ionizing Radiation
Nuclear events in Hiroshima and Nagasaki testify to the carcinogenic potential of
ionizing radiation. Long-term follow up studies of the atom bomb survivors from
Hiroshima and Nagasaki reveal radiation to be a universal carcinogen, capable of
inducing cancer in most tissues at all ages, including the foetus (Pierce et al., 1996;
Little, 2000). X- and gamma-emissions induce the formation of hydroxyl radicals
from water (radiolysis) which may subsequently attack DNA to produce DNA strand
breaks (see 1.3.Lb). DNA double strand breaks allow for non-reciprocal
recombination events and the formation of aberrant chromosomes, perhaps critical
events in tumourigenesis (Duesberg et al., 2000). The major clinical effects of lung
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irradiation are conventionally divided into two stages: radiation pneumonitis and
radiation fibrosis. Pneumonitis can be regarded as the episode during which the
specific effects of lung damage are expressed and fibrosis as the subsequent wound-
healing phase. One reason for this opinion is provided by the chronology of changes
following thoracic irradiation. Phillips and Margolis (1972) irradiated the thorax of
mice in an atmosphere of 5% oxygen. Deaths occurred between 80 and 160 days
later and were due to pneumonitis. The survivors did not die immediately afterward;
this has held true in experiments by others also (Kurohara & Casarett, 1972). It is
additionally noteworthy that mice that are irradiated while breathing 100% oxygen
exhibit greater mortality at 7 months than mice breathing atmospheric air (Gross,
1994). These observations highlight the critical importance of oxic conditions in
pathological sequelae, and indicate that pneumonitis is a dose-limiting consideration
in thoracic radiotherapy (Gross, 1994). It has also been shown that inhibition of
collagen synthesis does not greatly reduce mortality in irradiated rats (Gross, 1994),
suggesting that fibrosis is not a factor in mortality due to lung irradiation.
Consideration of the pathogenesis of radiation reactions in the lung therefore
concentrates on the mechanisms of the acute episode of radiation pneumonitis and
the events leading up to it, a process that is probably similar in humans and
experimental animals.
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1.4. BIOLOGY OF p53
1.4.a. Biology of p53
The p53 tumour suppressor protein is a short-lived, latent transcription factor which
is activated and stabilised in response to a wide range of cellular stresses including
DNA damage, mitotic spindle damage and activated oncogenes (for recent review
see Ljungman, 2000). p53 was discovered more than 20 years ago by virtue of its
association with SV40 T antigen (Lane and Crawford, 1979). Initial p53 expression
studies demonstrated that many immortalised and primary human tumour cell lines
expressed elevated levels of p53 relative to the amounts expressed in normal wild-
type cells (Zakut-Houri et al, 1983). The notion that p53 possessed cellular
transformation associated properties was supported by further experiments which
demonstrated that elevated levels of p53 expression could co-operate with activated
Ha-Ras and transform primary fibroblast cells in culture (Eliyahu et al, 1985). Since
those early days, there has been a plethora of data supporting the alternative
hypothesis that p53 is an inhibitor of cellular transformation, and that accumulation
of wild-type p53 protein following genotoxic stress reflects an attempt to preserve
genomic integrity. The extravagant significance of p53 in regulating the integrity of
the genome is supported by several observations, including: 1) the majority of
human cancers have lost wild-type p53 function (Hollstein et al., 1994); 2) humans
and mice with p53 mutations develop tumours early in life (Purdie et al., 1994; Jacks
et al., 1994); 3) p53 deficient embryos are susceptible to spontaneous exencephaly
(Armstrong et al., 1995; Sah et al., 1995); 4) p53 deficient mice display increased
radiation and chemical carcinogenesis (Lee et al., 1994; Harvey et al., 1993); 5)
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damaged embryos are less frequently aborted in mice that lack p53 (Komarova et ah,
1997). Elegant animal models have demonstrated that p53 dysfunction is commonly
associated with either tumourigenesis or tumour progression in many cell types, and
lesions affecting wild-type p53 gene expression are the most frequently observed
molecular abnormalities in a wide spectrum of human malignancies (Hollstein et ah,
1994). Accumulation of p53 protein is observed in certain cell types following DNA
damage, and is associated with the induction of apoptosis and/or growth arrest
(Midgley et ah, 1995). It is hypothesised that it is this 'p53 response' that underlines
the tumour suppressor properties of p53 relevant to human malignancy.
1.4.a.l. p53 Structure and Function
p53 is a 53kDa phosphoprotein that can be subdivided into an N-terminal
transactivation domain, a proline-rich domain, the core DNA-binding domain, and
the C-terminal oligomerization and regulatory domains (Figure 1.4.i). Central to the
regulation of p53 is its interaction with the MDM2 oncoprotein, which blocks p53
transactivation function by binding to a region of the transactivation domain
(reviewed in Meek, 1999). MDM2 targets p53 for ubiqitin-mediated proteolysis and
thus mediates rapid turover of the p53 protein. In addition to this role in regulating
p53, the MDM2 gene is itself stimulated by p53-dependent transactivation.
Consequently, MDM2 participates in an autoregulatory feedback loop which keeps
p53 under tight control under normal conditions of cell maintenance. These findings
suggest that MDM2 is pivotal to the regulation of p53 protein. MDM2 is frequently
overexpressed in human lung adenocarcinoma, and in one study was observed in
over 30% of cases. It is possible that MDM2 overexpression represents an
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Poly-proline
Figure 1.4.i — A model describing the structure and function of p53. The N- terminal, or
transactivation domain of p53 binds various proteins associated with the basal transcriptional
machinery including TBP (TATA-binding protein) (Horikoshi et al, 1995), TAFn40 and TAFn60
(TATA-associated factors; Thut et al, 1995) and p300/CBP (Gu and Roeder, 1997 and Lill et al,
1997). The core domain encompasses the DNA binding domain, additionally the site recognised by
SV40 T antigen, and is a mutational hotspot of the p53 locus. The C- terminal domain of p53
contains both the regions necessary for protein tetramerisation and for non-sequence specific DNA
binding. Monomer units of p53 protein form homodimer complexes through direct interaction
between their respective tetramerisation domains (amino acids 320-360), and functional p53
tetramers subsequently form as a result of p53 homodimerisation. The non-sequence specific DNA
binding region within the C- terminal domain of p53 (amino acids 363-393) confers ability to bind to
both damaged DNA and denatured DNA templates, and may represent a mechanism by which p53
detects DNA damage within the cell (Levine et al, 1997). This latter sub-domain additionally enables
p53 to re-anneal both complementary RNA and single stranded DNA (Wu et al, 1995), and may
indicate a role in transcription-coupled repair.
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epigenetic mechanism of ablating p53 function. However, it is noteworthy that
oncogenic properties of MDM2 distinct from its regulation of p53 have been
observed in certain cell types, such as mammary epithelium (Lundgren et al., 1997).
1.4.a.2. p53 Activation
The p53 response is triggered by many different stresses involving both DNA-
damaging and non-DNA damaging agents (Figure 1.4.ii). These include
ribonucleotide synthesis inhibitors, thymidine dinucleotides, media depletion,
hypoxia, antioxidants, DNA strand breaks, bulky DNA lesions, DNA topoisomerase
inhibitors, blockage of RNA polymerase II, heat shock, cold shock, viral infection,
pRb deregulation, and oncogene expression. The emerging picture from cellular and
molecular studies is that multiple, distinct sensors and pathways exist that activate
p53 in response to stress.
The mechanisms by which p53 is activated are best understood in response to the
DNA damaging agents UV and ionizing radiation. Both UV and ionizing radiation
induce a rapid induction of p53 in certain mammalian cell types. UV induces bulky
adducts in DNA that, if formed in the transcribed strand of an active gene, will
impede the elongation of RNA polymerases. Blockage of RNA polymerase is
additionally accomplished by cisplatin and nitrogen mustard, and may represent a
common trigger for p53 accumulation following exposure to bulky adduct-forming
agents. Ionizing radiation induces a number of different types of DNA lesions, of
which strand breaks are considered the most relevant to p53 stabilisation.
Notwithstanding this, microinjection of DNA with free ends into mammalian cells is
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Figure 1.4.ii. The p53 response is triggered by many different stresses involving both
DNA-damaging and non-damaging agents. These include ribonucleotide synthesis
inhibitors (Linke et al., 1996), thymidine dinucleotides (Eller et al., 1997), media
depletion (Zhan et al., 1993), hypoxia (Graeber et al., 1994), antioxidants (Plaumann et
al., 1996; Liu et al., 1998), DNA strand breaks (Nelson & Kastan, 1994; Midgley et al.,
1995), bulky DNA lesions (Maltzmann & Czyzyk, 1984; Fritsche et al., 1993), DNA
topoisomerase inhibitors (Fritsche et al., 1993; Tishler et al., 1993), heat shock (Graeber
et al., 1994; Matsumoto et al., 1994), cold shock (Ohnishi et al., 1998), viral infection (de
Stanchina et al., 1998; Debbas & White, 1993), pRb deregulation (Bates et al., 1998;
Hsieh et al., 1999), and oncogene expression (Zindy et al., 1998; Palmero et al., 1998).
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sufficient to activate p53. The p53 phosphorylation events characteristic of
radiation-injury are thought to be mediated by members of the PI-3 kinase family.
Activation of p53 in response to DNA damage is complex, requiring multisite
phosphorylation and acetylation at key residues of the p53 protein (Figure 1.4.iii;
reviewed in Meek, 1999). N-terminal phosphorylation permits recruitment of key
transcription factors including p300/CBP and PCAF, which in turn acetylate residues
at the C-terminus of p53 leading to stimulation of the site-specific DNA binding
function. Phosphorylation of human p53 occurs in the N-terminus domain at serines
15, 20, 33, and 37 in response to ionising and UV radiation, and DNA-damaging
drugs (Meek, 1999; Shieh et al., 1997; Banin et ah, 1998; Canman et ah, 1998; Shieh
et ah, 1999). The serine 15 phosphorylation site is juxtaposed to the MDM2 binding
site, and phosphorylation of p53 at serines 15 and 37 can block its interaction with
MDM2 in vitro (Pise-Masison et ah, 1998; Shieh et ah, 1997). The consequence of
disrupting the p53-MDM2 complex is the release of p53 from the inhibition of
transactivation and the prevention of further proteasome-mediated p53 degradation.
An attractive quality of this model is that it explains how p53 could be both induced
and activated simultaneously.
In response to ionizing radiation, the N-terminus of p53 is phosphorylated by, at a
minimum, three different DNA damage-responsive protein kinase activities, each of
which belongs to the PI-3 kinase family. These are the DNA activated protein kinase
(DNA-PK), the ATM kinase, the product of the ATM gene mutated in the genetic









Figure 1.4.iii - A model describing DNA damage-induced p53 activation.
Phosphorylation of the N-terminal transactivation domain occurs in response to
DNA damage, displacing Mdm2 and facilitating recruitment of key transcription
factors, which in turn acetylate the C-terminus, inducing tetramerisation and
stimulating site-specific DNA binding.
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DNA-PK phosphorylates human p53 at serines 15 and 37 in vitro and is dependent
for activity of interaction with double-stranded DNA structures containing nicks or
gaps (Anderson, 1994; Jackson & Jeggo, 1995). ATM and ATR also phosphorylate
p53 at serine residues 15 and 37, and are additionally associated with
hypersensitivity to DNA-damaging agents (Meek, 1999). p53 induction displays
delayed kinetics in irradiated cells isolated from A-T individuals (Enoch & Norbury,
1995), but not SCID mice (deficient in DNA-PK), insinuating ATM as the dominant
p53-activation factor in the ionizing radiation response in vivo.
1.4.b. DNA Damage Responses of p53
In response to DNA damage, p53 affects transcriptional regulation of gene
expression and inhibits tumour cell growth by either inducing G1 growth arrest or
apoptosis (Figure 1.4.iv). Some 100 genes are thought to be transactivated by p53.
In addition, p53 reduces transcription of other genes, a mechanism at least partially
accomplished by histone deacetylation. The great majority of p53 mutations
observed in human tumours are found in the DNA-binding domain of the protein,
abolishing transactivation function of p53. Consequently, transactivation functions
of p53 are considered integral to its role in tumour suppression.
The transactivation capacity of p53 in vivo was initially demonstrated by the use of
transgenic mice expressing a lacZ reporter gene in a p53-dependent manner (Gottlieb
et ah, 1997; Komarova et al., 1997). Following y-irradiation, sites of maximal
reporter expression colocalised with sites of maximal p53 stabilisation in most
tissues examined of adult mice. Flowever, it is noteworthy that a p53
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Figure 1.4.iv. A model describing transactivation functions of p53. p53 upregulates
expression of Bax, p21, and Mdm2 and represses Bcl-2 expression thereby impacting
on both the cell cycle and steps that initiate the caspase cascade. Autoregulation of p53
is accomplished by induction of Mdm2, a p53 target gene. Regulation of Mdm2 is
additionally dependent on the pi9 gene product.
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stabilisation/transactivation infidelity was observed in certain elements of the spleen;
specifically, although both red and white compartments of the spleen exhibited high
levels of p53 stabilisation in response to DNA damage, reporter gene expression was
only detected in the red pulp. In other cell types, such as the hepatocyte (Bellamy et
al., 1997b), p53 transactivation, but not stabilisation, is a feature of radiation-injury.
Consequently, the relationship between p53 stabilisation and transactivation would
appear cell-type specific, and may vary between different cell lineages.
1.4.b.l. Apoptosis
Apoptosis is an evolutionary conserved, morphologically defined form of cell death
characterised by chromatin condensation and collapse of the nucleus. p53 status is
critical for the induction of a rapid apoptotic response in many mammalian cell types
in response to DNA damage (reviewed in Bellamy, 1997c) and, by removing the
damaged cell, is considered a major cellular strategy in the prevention of
tumourigenesis. Consequently, although not proven, it has been suggested that the
attenuated apoptotic responses exhibited by p53 deficient cells contribute to an
overall increase in the probability of their malignant conversion.
p53-dependent apoptosis can be triggered by a variety of stimuli including DNA
damage, oncogene activation, and growth factor withdrawal. In vitro studies
demonstrate that p53 can induce apoptosis through both transactivation dependent
and independent mechanisms. Indeed, cells cultured in the presence of both
actinomycin D and cycloheximide (inhibitors of RNA and protein synthesis
respectively) display p53-dependent apoptosis following DNA damage (Caelles et
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al., 1994) or c-myc overexpression (Wagner et al., 1994). It is additionally
noteworthy that a C-terminal deficient, and consequently transactivation deficient,
p53 molecule retains the ability to induce HeLa cell apoptosis in response to
inappropriate oncogene expression (Haupt et al., 1995). The mechanisms underlying
p53-dependent apoptosis in the absence of downstream gene transactivation remain
to be elucidated, however direct interaction between p53's C-terminal domain and
both XPB and XPD helicases appear to be essential in certain cellular contexts
(Wang et al., 1996). Furthermore, an ability of activated p53 to mediate the
translocation of the Fas receptor from Golgi appartus to the cell surface has been
observed in certain cell types, such as vascular smooth muscle cells (Bennett et al.,
1998). Activated p53 additionally stimulates interaction between FADD and the Fas
receptor, thus transiently sensitising cells to Fas-induced apoptosis (Bennett et al.,
1998).
p53 additionally induces apoptosis via transcriptional modulation of downstream
target genes. Of these, the family of Bcl-2-related proteins constitutes the
biologically most relevant class of apoptosis-regulatory gene products known to be
modulated by p53 (reviewed in Zamzani et al, 1998). Bcl-2 related proteins may
either promote cell survival (Bcl-2, Bcl-xL, Bcl-w, Bfl-1) or encourage cell demise
(Bax, Bcl-xs, Bad, Bak)(Cory, 1995; Kroemer, 1997; Reed, 1994; 1997; Thompson,
1995; Yang and Korsmeyer, 1996). The consensus is that the relative amount of
death agonists and antagonists from the Bcl-2 family constitute a regulatory rheostat
whose function is determined, at least in part, by selective protein-protein
interactions between family members (Figure 1.4.v). Notwithstanding this,
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Figure 1.4.v. A model describing protein-protein interactions
of bcl-2 family members. The death/life rheostat is mediated,
at least in part, by competitive dimerisation between selective
pairs of death agonists and antagonists (Sedlak et al., 1995).
Since each of the members of the Bcl-2 family is expressed in a
cell-type-, differentiation-, and activation stage-specific
fashion, a network of pairs of interacting proteins influences
cell fate.
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transgene-enforced overexpression of Bcl-2 and Bcl-xL confer apoptosis resistance to
a number of different tissues including lymphocytes (McDonnell et al., 1989;
Sentman et al., 1991; Strasser et al., 1991), neurons (Martinou et al., 1994),
hepatocytes (Lacronique et al., 1996), keratinocytes (Pena et al., 1997) and
mammary epithelium (Jager et al., 1997). By contrast, ectopic expression of
propapoptotic derivatives, such as Bax and Bcl-x , sensitises cells to apoptosis
induction following genotoxic insult (Pena et al., 1997; Brady et al., 1996) and
glucocorticoid stimulation (Brady et al., 1996). Knock-out studies have revealed that
Bcl-2 deficiency is deleterious for certain cell types, including lymphocytes
(Nakayama et al., 1994), melanocytes (Yamamura et al., 1996), intestinal epithelial
cells (Kamada et al., 1995), and some classes of neurons (Michaelidis et al., 1996),
whereas deficiency of Bcl-x causes intrauterine death accompanied by massive loss
of postmitotic immature neurons (Motoyama et al., 1995). Importantly, Bax -/- Bcl-
x-/- double knockout mice do not mainfest the increased cell death of immature
neurons observed in Bcl-x -/- mice (Schindler et al., 1997). Similarly, the thymic
hypoplasia characteristic of Bcl-2-/- mice is largely absent in mice also deficient in
Bax (Knudson & Korsmeyer, 1997), highlighting the importance of an equilibrium
between death agonist and antagonist proteins in the regulation of cell survival.
Bcl-2 and its homologues insert into intracelluar membranes, including those of the
mitochondria, and is suggested that regulation of apoptosis is dependent on protein-
protein interactions within the outer and inner mitochondrial membranes (Zamzami
et al., 1998)(see Figure 1.4.vi). Notwithstanding this, Bcl-2 overexpression prevents














Figure 1.4.vi - A model describing regulation of apoptosis by bcl-2 family members.
The mitochondrial permeability transition (PT) pore is a multiprotein complex
formed at the contact site between the mitochondrial inner and outer membranes,
exactly the same localisation at which Bax, Bcl-2 and Bcl-xL are particularly
abundant. Experiments involving the purified PT pore complex indicate that Bax,
Bcl-2, and Bcl-xL exert at least part of their apoptosis-regulatory function by
facilitating (Bax) or inhibiting (Bcl-2, Bcl-xL) pore opening.
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cytochrome c, and caspase activation typical of apoptosis (Kluck et al., 1997).
Furthermore, Bax, Bcl-2 and, Bcl-xL are particularly abundant at the contact site
between the mitochondrial inner and outer membranes, additionally the site of the
permeability transition (PT) pore complex from which A\ym and mitochondrial efflux
are regulated. Data obtained with isolated mitochondria indicate that Bax protein can
induce both A\j/m dissipation and cytochrome c release. This finding has been
confirmed in mammalian cells and yeast cells transfected with Bax (Manon et al.,
1997; Rosse et al., 1998; Xiang et al., 1996), suggesting that Bax acts to destabilise
mitochondrial membrane function and thus induce apoptosis via its interaction with
the PT complex.
In vivo, the p53-dependent apoptotic response is best understood following ionizing
radiation insult, which induces DNA strand breaks. In mice, there is consensus that
p53-dependent apoptosis is observed in thymocytes, splenocytes, and intestinal
enterocytes from approximately 4 hours following irradiation, and that this associates
with the induction of Bax. By contrast, intestinal cells and thymocytes of p53-
deficient mice do not display this rapid wave of apoptosis following ionizing
radaition injury. Instead, these cell types from p53-deficient mice exhibit apoptosis
at the later time points of 24-48 hours post-irradiation (Clarke et al., 1994; 1993). It
has been suggested that the p53-dependent wave of apoptosis reflects Bax
upregulation in intestinal cells and thymocytes of irradiated mice. However, Bax
deficient mice do not display the apoptotic defects characteristic of p53-null mice. In
this respect, it is noteworthy that p53 can inhibit the expression of Bcl-2 in cultured
cells, thus it is conceivable that p53 influences the expression of both target genes to
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promote apoptosis in vivo. Notwithstanding this, Bax and Bcl-2 deficient mice
display thymic hyperplasia and intestinal exfoliation, respectively, insinuating their
involvement in normal tissue dynamics. The genetic basis of the p53-independent
apoptotic pathway is not understood, but in considering their prominent role in
life/death decisions there is reason to suspect Bcl-2 family involvement.
1.4.b.2. Growth Arrest and Repair
p53 induces G1 and G2 growth arrests in mammalian cells, phenomena dependent on
the ability of p53 to transcriptionally activate the expression of downstream loci.
Initiation of p53 dependent cell cycle arrest appears to create a cellular environment
in which damaged DNA may be repaired with greater efficiency. The p2iWAF1/CIP1
gene product (p21) is induced by p53 in a range of cell types, and is a critical
determinant of DNA-damage induced growth arrest (Brugarolos et al., 1995; El-
Deiry et al., 1994; Waga et al., 1994; Li et al., 1994). p21 inhibits cyclin-dependent
kinase activity, thus inducing dephosphorylation of Rb and inhibition of the E2F
transcription factor complex (reviewed in Nevins, 1998). Consequently, p21,
although not a transcription factor, regulates a distinct network of genes involved in
cell-cycle progression, including several E2F regulated genes (Chang et al., 2000).
p21 has also been demonstrated to interact with proliferating cell nuclear antigen
(PCNA), a protein that facilitates DNA synthesis (Flores-Rozas et al, 1994; Waga et
al., 1994). PCNA is also involved in nucleotide excision repair (NER), but
interaction with p21 has been demonstrated to block DNA replication selectively
without affecting PCNA dependent NER (Li et al., 1994). The relationship between
p53, p21, and mediation of the Gl-S cell cycle checkpoint is not exclusive, however,
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as fibroblasts derived from mice deficient in p21 are still partially able to arrest at
Gl-S following DNA damage.
p21 induction is observed in murine lung epithelial cells following hyperoxia and
ionizing radiation insults, and in a mouse model of acute immune complex alveolitis
(McGrath, 1998; Macleod et al., 1995; Kuwano et al., 1997). In irradiated lung, p21
induction is p53-dependent, as determined by Northern analysis, and does not occur
in the lungs of p53-deficient mice (Macleod et al., 1995). It is hypothesised that p21
induction may reflect cell cycle changes in damaged lung.
Gadd45 is a growth arrest and DNA damage-inducible gene implicated in the p53-
dependent G1 and G2 growth arrests. Gadd45 directly interacts with PCNA in
response to DNA damage in such a manner as to enhance DNA repair whilst
inhibiting DNA replication (Hall et al., 1995). Gadd45 deficient mice exhibit several
of the phenotypes of p53-deficient mice, including genomic instability, increased
radiation carcinogeneis, and a low frequency of exencephaly. Consequently, it is
probable that that gadd45 is a critical component of the p53 pathway in most cell
types. However, gadd45 induction is p53-independent in the lungs of irradiated
mice, as determined by Northern analysis, and occurs equally in p53 deficient mice.
The mechanisms of regulating gadd45 expression in the lung following DNA
damage are not understood.
In addition to inducing cell cycle arrest, which facilitates DNA repair, p53 has been
directly implicated in the repair of damaged DNA. p53 has 3' to 5' exonuclease
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activity and the ability to recognise and bind damaged DNA template. Furthermore,
the C-terminal domain of p53 is able to interact with the XPB and XPD helicase
components of the TFIIH repair complex (Wang et ah, 1996). The in vivo
significance of these interactions has yet to be established, however the in vivo
consequences regarding p53 status and mutation rate are presented and discussed
below.
1.4.c. p53 and Mutation Frequency
Abrogation of wild type p53 function is predicted to lead to an increase in the
number of cells bearing DNA damage as a consequence of altered apoptotic and
DNA repair profiles. Experiments designed to test these predictions suggest that p53
dependent differences may only become apparent following exogenous damage.
Two different groups have used a transgene target to monitor spontaneous mutation
frequency, but in both cases no p53 dependent differences were observed (Sands et
ah, 1995; Nishino et ah, 1995). By contrast, experiments using either short pre-B
cell cultures (Griffiths et ah, 1997) or a transfected fibroblast line (Yang et ah, 1995)
have provided data in support of a p5 3-dependent decrease in the number of mutation
bearing cells following DNA damage. In vivo experiments utilising the endogenous
locus Dlb-1 as a marker of mutation have demonstrated a p53 dependent decrease in
mutation frequency in the murine small intestine (Clarke et ah, 1997), although this
was only observed at high levels of DNA damage. A criticism of these studies is that
by concentrating on a relatively small target locus, they do not address the possibility
of clastogenic damage, such as that induced by ionizing radiation. However, taken
together, these different experiments do support a role of p53 in preventing the
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acquisition of mutations, but it is clear that it is not the sole mechanism, particularly
at low levels ofDNA damage.
1.5. p53 AND LUNG DISEASE
1.5.a. p53 and Lung Cancer
Lung cancer is the leading cause of cancer death in the Western world (WHO, 1999).
Lung cancer incidence is sporadic within the population with tobacco smoking
identified as a major aetiological agent (WHO, 1999). Tobacco smoke is DNA
damaging, and induces DNA strand breaks and point mutations in mammalian cells
(Poli et al., 1999; Hecht, 1999). Progressive accumulation of mutations in specific
oncogenes and tumour suppressor genes compromises genomic integrity and is
considered a hallmark of tumourigenesis. It has been suggested that specific
mutations induced by carcinogens in tobacco smoke may explain the natural history
of lung malignancy (Tuveson & Jacks, 1999).
A hotspot for point mutations and deletions in lung cancer is the gene encoding the
stress protein p53 (Takahashi et al., 1989; Bennett et al., 1999). p53 is frequently
mutated in human malignancy and its presence is considered rate-limiting in tumour
progression. In certain cell types, wild type p53 protein affords an invaluable DNA
damage response and transcriptionally modulates a battery of downstream genes
involved in growth control, DNA repair, and apoptosis following genotoxic insult
(reviewed in El-Deiry, 1998). Growth arrest facilitates DNA repair, and is
instrumental in maintaining genomic integrity. Apoptosis is a morphologically
defined form of cell death and, by removing the damaged cell, is considered a major
cellular strategy in the prevention of tumourigenesis. Consequently, in certain cell
types, absence of p53 permits propagation of mutant cells following genotoxic insult
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(Griffiths et al., 1997; Clarke et al., 1997). Point mutations of the p53 locus
observed in human lung malignancy frequently ablate DNA binding and hence
abolish transactivation ability of the p53 protein (Bennett et al., 1999). Tumour
suppressor properties of p53 in the lung thus abide within its ability to transactivate
downstream genes. In lung adenocarcinoma, where progression of the disease is
histologically defined, mutation of p53 occurs early in tumour formation, possibly at
a preneoplastic stage (Kitamura et al., 1995; Kitamura et al., 1996). Presumably, loss
of p53 confers a selective advantage in preneoplastic lesions of the lung and is
mutated accordingly. However, the mechanism by which p53 loss contributes to
lung carcinogenesis is not understood.
Knockout mice, germline deficient in p53, display a complex phenotype of genomic
instability, increased radiation carcinogenesis, and a low frequency of exencephaly
(Fukasawa et al., 1997; Donehower et al., 1992; Harvey et al., 1993; Purdie et al.,
1994; Jacks et al., 1994; Armstrong et al., 1995; Sah et al., 1995). p53 deficient mice
additionally display spontaneous lung adenocarcinoma, albeit infrequently. It is
probable that lung adenocarcinoma represents malignancy of the Clara cell, a
progenitor species of the small airways (Massaro et al., 1994). Indeed, targeted
expression of SV40 T antigen in small airway epithelium robustly induces
adenocarcinoma in transgenic mice, and tumours of these mice frequently express
Clara cell markers in vivo (Wikenheiser et al., 1992; Wikenheiser & Whitsett, 1997).
p53 influences the response to DNA damage in certain cell types, and loss of p53 has
many effects including decreased apoptosis, cell cycle checkpoint disturbances,
reduced DNA repair, and abnormalities in cytokinesis (Ko & Prives, 1996). It is
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possible that tumour suppressor properties of p53 in the small airways reflect its role
in the pluripotent Clara cell.
1.5.b. p53 and Acute Lung Injury
Effects of p53 in metaplastic lung have been partially elucidated in the context of
DNA damage, and include induction of the cell cycle-dependent kinase inhibitor p21
(Macleod et ah, 1995), and the repair enzyme O-6-methylguanine DNA
methyltransferase (MGMT) (Rafferty et ah, 1996) (see 1.4.b). Induction of the
death-related gene Bax is a feature of acute lung injury (Guinee et ah, 1997), and
may represent an additional p53 response of lung epithelium. In certain cell types,
notably those of the gut, thymus, and spleen, DNA damage-induced Bax induction is
p53-dependent and is associated with apoptosis (Kitada et al, 1996). Bax induction
is a feature of acute lung injury, and localises to bronchioalveolar cells (Guinee et ah,
1997), although its association with apoptosis is unclear, as discussed below.
p53 stabilisation is observed in human small airway epithelium in the inflammatory
condition Adult Respiratory Distress Syndrome (ARDS), and in mice following
hyperoxia and bleomycin exposure (Guinee et al., 1996; O'Reilly et ah, 1998;
Okudela et al., 1999). ARDS is a complication of smoke inhalation, acute exposure
to radiation, and sepsis and pathological features of the disease include small airway
cell apoptosis and oedema. High-dose radiation, bleomycin, and hyperoxia
treatments model ARDS in experimental animals. Mice treated with these toxins
display many features of ARDS, including vascular permeability changes and
apoptosis of small airway cells (Mantell et al., 1999). Hyperoxia, bleomycin, and
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ionizing radiation increase the amount of reactive oxygen species (ROS) in the cell.
ROS are both genotoxic, causing DNA strand breaks, and proinflammatory, inducing
cytokine release. Notwithstanding this, the lungs of ROS-treated mice display p53
stabilisation, TNF-alpha induction, and apoptosis of airway cells (O'Reilly et ah,
1998; Okudela et ah, 1999; Ortiz et ah, 1998). Endothelial cell apoptosis is Acidic
Sphingomyelinase (ASMase)-dependent in irradiated lung, and does not occur in
ASMase-deficient mice (Santana et ah, 1996). ASMase mediates TNF-alpha
signalling in endothelial cells, and ASMase mice are deficient in TNF-alpha, but not
p53, responses to radiation injury. Apoptosis of airway epithelial cells is an
additional feature of acute lung injury, as determined by TdT-mediated dUTP end-
labeling (TUNEL) of DNA strand breaks, an in situ method for detecting apoptosis
(Kazzaz et ah, 1996; Bardales et ah, 1996; Guinee et ah, 1996). TUNEL indices
increase in airway cells following ROS-exposure, and are enhanced in p53-deficient
mice (Okudela et ah, 1999). It is thus conceivable that p53 influences the response
to injury via a role in apoptosis and, indeed, such a role has been hypothesised in the
airways (Guinee et ah, 1996). However, other reports suggest that the pathogenic
response to ROS is p53-independent, and instead correlates with the aforementioned
TNF-alpha induction (Santana et ah, 1996; Ortiz et ah, 1998). Discrepancies in the
literature may reflect the current concern over the accuracy of TUNEL in
determining apoptosis. It is documented that TUNEL staining does not discriminate
between necrosis and apoptosis in certain cell types (Grasl-Kraupp et ah, 1995).
DNA fragmentation is additionally a feature of ROS-exposure (Dizdaroglu, 1993),
and it is possible that ROS generated by hyperoxia, bleomycin, and ozone induce
strand breaks detectable by TUNEL. Consequently, TUNEL is a useful marker, but
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not a surrogate method of determining apoptosis, which still requires the
demonstration of distinct morphological features. The relationship between p53, the
bcl-2 family, and epithelial cell apoptosis is thus currently unresolved in the context
of acute lung injury, and requires clarification.
In this analysis, the author sought to identify functions of p53 in small airway
epithelial cells. p53 stabilisation has been observed in the small airways previously,
but its significance is unclear. To determine the role of p53 in bronchioalveolar
cells, the author exploited gene targeted mice, germline deficient in p53, to establish
unequivocally the functions of p53 over a 72-hour time course in response to
ionizing radiation. Apoptosis was evaluated by two methods - morphology and in
situ end-labelling (TUNEL), and regulation of Bcl-2 family transcription was
assessed by sensitive ribonuclease protection assays of whole-lung extracts as there
is controversy on this subject. This thesis additionally explored the hypothesis that
Clara cells, as a major progenitor species of the small airways, are relevant to
neoplasia of the lung and centriacinar emphysema, and that phenotypic effects of p53
deficiency would predominate in this cell type. A method for extracting, isolating,
and culturing Clara cells from the mouse has been described previously (Masek &
Richards, 1990) and was incorporated into this analysis to facilitate a greater
understanding of the role of p53 in small airway epithelial cells.
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1.6. TRANSGENIC MOUSE MODELS OF LUNG INJURY
Knowledge of biochemical and physicochemical interactions helps in understanding
injury mechanisms and highlights new avenues of prophylaxis and treatment.
Transgenic technology offers a way of examining the genetic determinants of acute
lung injury, and has been used to illustrate the in vivo importance of key genes in
damage response pathways. Control elements of genes expressed in a lung-selective
manner have been identified, and have been used to express transgenes in subsets of
respiratory epithelial cells in the developing and mature lung. Distinct temporal and
spatial patterns of expression are observed with such constructs, depending on the
promoter element used and the species from which it was cloned (Table 1.6.i). Of
these, the SP-C promoter has been most extensively studied. Cis-acting sequences
from human Surfactant Protein-C gene confer pulmonary-specific gene expression in
transgenic mice. Unlike the endogenous murine SP-C promoter, which drives
expression specifically in type II alveolar cells of adult mice, transcriptional elements
from the human SP-C gene direct expression in the primordial respiratory epithelium
of mid-gestation embryos, and in both Clara cells and type II cells of adult transgenic
mice.
Existing mouse models of lung injury exploit lung-epithelium specific promoters to
address the functional consequences of gene overexpression in vivo. By the use of
such models, significant progress has been made in understanding mechanisms by
which cytokines and antioxidant enzymes influence remodeling processes in the lung
(Table 1.6.ii). These studies additionally highlight the potential importance of lung
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bronchiolar/alveolar type II (Bruno et
al., 1995)
bronchiolar/alveolar (Bohinski et al.,
1994; Bruno et al., 1995)
bronchiolar/alveolar type II (Glasser
et al., 1991; Wert et al., 1993)







nonciliated bronchiolar (Hagen et al.,
1990; Stripp et al., 1992)
uterus/nonciliated bronchiolar (Hagen
et al., 1990)
bronchiolar/alveolar type II (Bohinski
et al., 1994; Bruno et al., 1995)
SP, surfactant protein; CC10, Clara cell lOkDa protein; CCSP, Clara cell secretory protein
(homologue of CC10); TTF, thyroid transcription factor.
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Table 1.6.ii - Transgenic mouse models of lung injury




SP-C Tumoiirigenesis and immortalization of
epithelial cells (Wikenheiser et al., 1992,
1993)
CCSP Tumourigenesis (Demayo et al., 1991)
SP-C Lung fibrosis and altered morphogenesis
(Korfhagen et al., 1994)
SP-C Altered morphogenesis (Zhou et al., 1996)
TNF-a SP-C











Lung inflammation (Miyazaki et al.,
1995)
Altered morphogenesis (Peters et al.,
1994)
Type II cell hyperplasia (Huffman Reed et
al., 1997)
Lung inflammation, fibrosis and
emphysema (Hoyle et al., 1999)
Airway inflammation (DiCosmo et al.,
1994); Protection from hyperoxic acute
lung injury (Ward et al., 2000)
Bronchial remodeling and airway
inflammation (Tang et al., 1996);
Protection from hyperoxic acute lung
injury (Waxman et al., 1998)
Protection from hyperoxic acute lung
injury (Folz et al., 1999)
SV40, simian virus 40; TGF, transforming growth factor; CFTU, cystic fibrosis transmembrane conductance
regulator; TNF, tumour necrosis factor; FGF, fibroblast growth factor; GM-CSF, granulocyte-macrophage
colony-stimulating factor; PDGF, platelet-derived growth factor; IL, interleukin; SOD, superoxide dismutase;
SP-C, human surfactant protein C; CC10, rat Clara cell lOkDa protein; CCSP, rabbit Clara cell secretory
protein.
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epithelial cells in disease processes. A caveat of existing lung-transgenic models is
that they are restricted to overexpression studies, and do not address the significance
of gene deficiency in lung epithelial cells in vivo.
One method for addressing the significance of gene deficiency in vivo is conditional
gene targeting. Conditional gene targeting is an invaluable method for overcoming
the high incidence of embryonic lethality observed in constitutive knockouts, and for
discerning the in vivo significance of gene deficiency in specific tissues. Two
methods of conditional gene targeting, the Cre-lox and Flp-frt systems, are in
existing use in mammals. Of these, the Cre-lox system has been used with the most
frequent success. The Cre/lox recombinase system evolved within bacteriophage P1
as a mechanism to maintain correct unit copy segregation of the prophage within host
cells. Bacteriophage PI encodes the 38-kDa Cre recombinase that catalyses site-
specific DNA recombination between 34-base pair repeats termed loci of
recombination or 'lox' sites (Sauer & Henderson, 1988). Cre recombinase,
expressed ectopically in mammalian cells, induces either deletion or inversion of the
sequences flanked by the lox sites dependent upon lox site orientation (Figure 1.6).
The Cre-lox system can function in a highly efficient manner in directing tissue-
specific, site-specific, and heritable chromosomal DNA recombination events and
has been used to generate tissue-specific knock-outs, inducible knock-outs, and site-
directed chromosomal translocations in transgenic mice in vivo (Table 1.6.iii). The
ability to generate temporally and/or spatially restricted gene alterations largely
resolves two of the main problems associated with conventional gene 'knock-outs',









Invertedr peatsofloxPflankingth geneofinterest loxP
loxP
\Intermediate
Deletedall le, incorporating oneIoxPsit
+
Recombinedcircular product,incorporating excisedallelendo loxPsite
Intermediate
Invertedallele
Figure1.6.Amod ldescribingtheCre-loxystemofite-dir ctedrecombination.R c mbinatloxPit si ebyr recombinase(den tedbyyellowarrows).Excisi nfthfloxel lei nergeticallyavourablv rr eraction. Inversionisreversiblethcontinuedpre encfC .


















Barlow et al., 1997
Selbert et al., 1998
Tarutani et al., 1997
Agah et al., 1997
Nelson et al., 1998
Ray et al., 1998
Gustafsson et al., 2001
Marino et al., 2000
Regan et al., 2000
Gu et al., 1994
Zhu et al., 2001
Clausen et al., 1999
St-Onge et al., 1996
Kuhn et al., 1995
Feil et al., 1996
Chromosomal Translocations
Modelling the t(8;21) reciprocal exploits Nestin-driven Cre to overcome
translocation found in human acute myeloid lethal effects in early embryogenesis
leukaemia Buchholz et al., 2000
Modelling the t(9;l 1) reciprocal
translocation found in human leukaemia
exploits ubiquitously expressed Cre
(deleter mice, Schwenk et al., 1995)
Collins et al., 2000
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developmental compensation.
Recently, in this department, a SP-C/Cre transgene has been developed in which the
3.7kb fragment of the human SP-C promoter described previously (Glasser et al.,
1991; Wert et al., 1993; see Table 1.6.i) is used to express Cre recombinase
specifically in small airway epithelial cells of transgenic mice (S.O'Dea, ongoing
work). A single founder mouse genotypically positive for Cre was generated by
blastocyst injection of the SP-C/Cre construct, and was crossed onto a Floxed mouse
line (Floxed DNA Ligase I) to facilitate analysis of Cre-mediated recombination in
vivo. As an additional project of this thesis, the author sought to determine the
feasibility of this approach in attaining conditional gene targeting in the lung, with
the eventual goal of generating improved mouse models of lung injury.
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1.7. AIMS
The aims of this thesis are the following:
1) To describe the effects of DNA damage in small airway epithelial cells in
terms of growth arrest, apoptosis, and gene expression
2) To discern the role of p53 in small airway epithelial cells in vivo, and in
primary Clara cell culture
3) To determine the feasibility of Cre-lox conditional gene targeting in small
airway epithelium
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2. MATERIALS AND METHODS
2.1. IN VIVO STUDIES
2. l.a. DNA-damaging azents
2.1.a.l. Irradiation
Mice were 5 Gray y-irradiated by a Cs-137 source at 0.33 Gy/minute. Unirradiated
controls were otherwise transported and handled identically. At 2, 4, 6, 8, 24, 48 and
72 hours following irradiation, mice were killed and tissues harvested. The left lung
was transferred to a vial of formalin for fixation and paraffin embedding. The right
lung was transferred to a cryotube and snap frozen in liquid nitrogen for subsequent
RNA and protein extraction.
2.1.a.2. Methylating Agents
Mice were injected intraperitoneally with 50mg/kg MNNG (N-Methyl N-Nitro N-
Nitrosoguanidine, Sigma). At 6 and 24 hours post-injury, mice were killed and
tissues harvested for histology and protein analysis, as described previously (see
section 2.1.a.l).
2.1.a.3. Alkylating Agents
Mice were injected intraperitoneally with lOmg/kg Nitrogen Mustard
(Mechloroethamine Hydrochloride, Sigma). At 6 and 24 hours post-injury, mice
were killed and tissues harvested for histology and protein analysis, as described
previously (see section 2.1 .a. 1).
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2.l.b. Gene-tarseted mice
Generation of the homozygous p53-deficient mice used in these experiments has
been described previously. Briefly, murine E14 embryonic stem cells (derived from
strain 129/Ola) bearing a targeted deletion of exons 2 through 6 of the p53 gene were
injected into blastocysts to generate germline chimaeras, which were bred to
homozygousity. The targeting construct consisted of a fragment from which intron 1
of the p53 gene, ligated to a pgk-neo cassette and a 5kb fragment that incorporated
exons 7-11 of the p53 gene. The neo cassette contained numerous STOP codons in
all three reading frames to prevent downstream transcription of the truncated gene.
p53 genotypes were established by a standard operating procedure, specifically, a
PCR strategy of DNA prepared from tail biopsies of appropriate lines (progeny of
Het x Het crosses). Alleles were selectively amplified by using a primer for intron 7
(common to both genotypes) and primers specific for exon 6 (wild type) and the neo
construct.
Mice used in the experiments described here were outbred on a mixed background,
segregating for 129, Ola, and Balb/c. For each experiment the mice were age and
sex-matched, and were littermates if possible. p53 genotype was rechecked on tail
samples after killing. The mice were housed in plastic cages in a room with a 12
hour day-night cycle and controlled temperature and humidity. They were given a
standard diet and water ad libitum.
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2.I.e. Histology
Histological analysis of wild type and p53-/- mouse lungs was accomplished on 3pm
haematoxylin and eosin sections by the author and a pathologist (DJH).
2. l.d. Evaluation ofapoptosis
2.1.d.l. Morphology
The morphology of apoptosis was easily recognised by light microscopy on 3 pm
haematoxylin and eosin stained paraffin sections.
2.1.d.2. Terminal deoxynucleotidyl transferase-mediated dUTP nick end labelling
(TUNEL)
Endonucleolysis is considered a key biochemical event of apoptosis. DNA strand
breaks were detected on paraffin sections by the enzymatic in situ end labelling
method TUNEL. Terminal deoxynucleotidyl transferase catalysed the
polymerisation of nucleotides to free 3'-OH DNA ends in a template-independent
manner. Two TUNEL kits, In Situ Cell Death Detection Kit (Roche) and ApopTag
(Oncor) were used in accordance with the manufacturer's instructions. The former
kit exploited fluorescein as a label of dUTPs, whilst the latter used digoxigenin.
Incorporated dUTPs were detected on sections by anti-fluorescein (Roche) and anti-
digoxigenin (Oncor) antibodies, respectively. DNase I-treated sections served as a
positive control. Negative controls omitted TdT amplification step.
Fluorescein-labelled DNA strand breaks were undetectable by immunofluorescence,
hence peroxidase conjugated anti-fluorescein antibodies were necessary to visualise
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TUNEL reaction. Positively stained nuclei were visualised by Liquid DAB
Chromogen with DAB enhancer (Biogenex), used according to the manufacturer's
instructions.
2.I.e. Western analysis
Frozen tissue samples were homogenised and lysed in the presence of a cocktail of
protease inhibitors. The lysate was vortexed briefly and centrifuged at 10,000g for 2
minutes at 4°C to pellet cell debris. The supernatant was transferred to a fresh
Eppendorf tube and stored at -20°C for up to 2 months. Protein concentrations of
extracts were determined using a derivation of the Bradford method (BioRad Protein
Assay, BioRad) in accordance with the manufacturer's instructions. Comparisons of
Absorbance at 595nm relative to a standard curve of Bovine Serum Albumin
facilitated determination of protein concentration.
SDS-polyacrylamide gel electrophoresis was accomplished on precast gels in a
XCell IIrM tank (Novex) in accordance with manufacturer's instructions. An
appropriate amount of protein was diluted 1:1 with loading buffer, boiled for 1
minute, and loaded onto 4-10% Tris-HCl precast gels (Novex). Electrophoresis was
accomplished in NuPAGE™ running buffer (Novex) at a constant voltage of 100V
per gel for 2 hours, or until dye front reached the bottom of the gel. Protein was
transferred onto Hybond™ECL™ nitrocellulose membranes (Amersham) via
electrophoresis at a constant current of 250mA per gel for 90 minutes. Gel sandwich
apparatus (BioRad) and transfer tank (BioRad) were used in accordance with
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manufacturer's instructions. Transfer buffer was made up fresh and chilled to 4°C
prior to use.
Protein blots were transferred to 50ml centrifuge tubes. All subsequent steps were
accompished on a roller mixer. Blots were washed three times in TBST (5 minutes
each wash), and stained with Ponceau solution to assess equal loading and quality of
transfer. Blots were destained of Ponceau solution, washed three times in TBST (5
minutes each wash) and blocked in 10% Marvel (Nestle, UK) in TBST for 1 hour.
Blots were then subjected to immunolabelling.
2.1.e.l. p53 protein
Blots were incubated with CM5 rabbit polyclonal antiserum (Novocastra), diluted
1:100 in 10% Marvel/TBST, overnight at 4°C. Blots were washed in TBST (3x5
minute wash steps) and incubated with peroxidase-conjugated donkey-anti rabbit IgG
(Santa Cruz), diluted 1:2,000, for 30 minutes at room temperature. Visualisation
was accomplished by chemiluminescent labeling. This stepwise protocol involved
incubation with ECL™ (Amersham), exposure to ECL™ film (Amersham), and
development of films (Hyperprocessor, Amersham), all carried out in accordance
with manufacturer's instructions. Developed films were digitally scanned (DeskScan
II, Hewlett Packard) and bands quantified with densitometry software (Aida,
Microsoft).
CM5 immunopositivity was not observed in whole lung extracts at a load of 40pg
protein per well. 150pg protein per well was required to unequivocally demonstrate
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immunopositivity in whole lung extracts,
positive control. Negative controls
accomplished in parallel.
20jag irradiated spleen extract served as a
omitted primary antibody, and were
2.1.e.2. p2lWAF1/CIP1 and bcl-2 family proteins
The presence of p2iWAF1/clP1 and Bax proteins in whole lung extracts was determined
by immunoblotting with goat polyclonal antibodies M-19 and P-19 respectively
(Santa Cruz). Primary antibodies were incubated for 1 hour at room temperature at
dilutions of 1:200 in 10% Marvel/TBST.
Blots were washed in TBST (3x5 minute wash steps) and incubated with peroxidase-
conjugated donkey-anti goat IgG (Santa Cruz), diluted 1:5,000, for 30 minutes at
room temperature. Visualisation and densitometry were accomplished by methods
described previously (see 2.1.e.l). bcl-x long and short isoforms were demonstrated
by immunoblotting with rabbit polyclonal antibody M-125, diluted 1:500 in 10%
Marvel/TBST, and incubated for 1 hour at room temperature. Subsequent steps were
identical to those used in p53 immunoblotting (see 2.1.e.l).
p21WAF1/cipi, Bax, and bcl-x175 proteins are of similar size, hence different blots were
required for each analysis. 40pg whole lung extract was loaded per well. Negative
controls omitted primary antibody, and were accomplished in parallel.
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2.1.f. Immunohis tochem is try
2.1.f.l. p53 protein
CM5 rabbit polyclonal antiserum (Novocastra), the antibody used in this analysis,
recognises seven distinct epitopes throughout the p53 protein. CM5 antibody has
been used previously to demonstrate p53 stabilisation in formalin-fixed paraffin
embedded murine tissues. Tissues derived from p53-null mice served as a negative
control, irradiated spleen from wild type mice served as a positive control.
CM5 immunohistochemistry was performed on formalin-fixed low temperature
paraffin sections on polylysine coated slides after microwave pretreatement (10
minutes, 700 Watts) in lOmM citrate buffer (pH 7.6). Positive-nuclei were
visualised by an avidin-biotin peroxidase labelling procedure.
Slides were rehydrated, exposed to 1.5% hydrogen peroxide/methanol for 15
minutes, washed in TBST, and incubated for 10 minutes in 20% swine serum/TBST.
Endogenous biotin was blocked using a kit (Vector laboratories), according to the
manufacturer's instructions. Paraffin sections were incubated with primary antibody,
diluted 1:500 in 20% swine serum/TBST, in a humid chamber overnight at 4°C.
Negative controls included irradiated spleen derived from p53-null mice, and wild
type irradiated spleen of which primary antibody was omitted. After washing in
TBST, biotinylated-swine anti-rabbit F(ab')2 (Dako) at 1:400 dilution was applied
for 30 minutes. Avidin-biotin horseradish peroxidase complex (Dako) was used as
the final labeling step and the chromogen was Liquid DAB (Diaminobenzidine) with
DAB enhancer (Biogenex), each applied according to the manufacturer's
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instructions. Slides were counterstained with haematoxylin, dehydrated, mounted in
pertex, and coverslipped.
2.1.f.2. bcl-2 family proteins
bcl-x long and short isoforms were immunohistochemically localised on paraffin
sections with M-125 rabbit polyclonal antiserum (Santa Cruz). Microwave
pretreatment in citrate buffer (10 minutes, 700W) produced superior immunostaining
to that accomplished with trypsin pretreatment or no pretreatment. Rehydrated
paraffin sections were blocked in 20% swine serum/TBST and incubated with
primary antibody overnight at 4°C (diluted 1:400 in 20% swine serum/TBST). After
washing in TBST, biotinylated swine anti-rabbit F(ab')2 (Dako) at 1/400 dilution
was applied for 30 minutes.
Avidin-biotin alkaline phosphatase complex (Dako) was used as the final labeling
agent and the chromogen was Vector Red. Advantages of Vector Red as a
chromogen include its ability to fluoresce under UV light, allowing enhanced
visualisation by immunofluorescence. Immunofluorescence was viewed under UV
illumination from a mercury lamp using a dichroic filter appropriate for Vector Red
(green) fluorescence.
Bax immunohistochemistry involved identical pretreatment and labeling steps as bcl-
x, with the exception that blocking and antibody incubation steps were accomplished
in 20% donkey serum/TBST. P-19 anti-Bax goat polyclonal antiserum, diluted
1:100, was incubated overnight at 4°C. Biotinylated donkey ant-goat IgG, diluted
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1:500, was incubated for 30 minutes at room temperature. Negative controls omitted
primary antibody.
2.1.f.3. p21WAF1/CIP1 protein
M-19 goat polyclonal antiserum was used to detect p21WA1'1/C1P1 on paraffin sections.
Trypsin and microwave pretreatments followed by avidin-biotin amplification steps
were insufficient to label p2lWAF1/clP1 on paraffin sections. Hence superior
amplification with biotinylated tyramide (NEN Life Sciences) was necessary to
assess protein distribution. Microwave pretreatment in citrate buffer (10 mins,
700W) improved immunodetection with the latter system.
Slides were rehydrated, exposed to 1.5% hydrogen peroxideAfi-HO for 15 minutes,
washed in TBST, and incubated for 10 minutes in 20% swine serum/TBST.
Endogenous biotin was blocked in accordance with manufacturer's instructions
(TSA™, NEN Life Sciences). M-19 goat polyclonal IgG, diluted 1:100, was
incubated overnight at 4°C, washed in PBS, and incubated with biotinylated donkey
anti-rabbit secondary antibody, diluted 1:500, for 30 minutes. Sections were washed,
and biotinylated derivatives amplified with a Tyramide Signal Amplification™ Kit
(TSA™, NEN Life Sciences) in accordance with manufacturer's instructions.
TSA™ exploited Horseradish Peroxidase activity to catalyse the deposition of biotin-
labeled tyramide onto tissue sections, resulting in the deposition of numerous biotin
labels. Biotin was labeled with avidin-biotin peroxidase complex (Dako), and
visualised with DAB. Added labels were deposited proximal to the enzyme site,
resulting in minimal loss of resolution.
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2.1.f.4. 5-Bromo-2'-deoxyuridine (BrdU)
24 hours prior to killing, mice were injected intraperitoneally with BrdU. Tissues
were harvested, formalin-fixed, and paraffin-embedded. Intestinal epithelium is
constitutively proliferating, and served as a positive control of BrdU incorporation.
Primary antibody was omitted in negative controls.
Slides were rehydrated, exposed to 1.5% H202 in distilled water for 10 minutes,
rinsed in PBS, and incubated in 5M HC1 for 1 hour, followed by three 5-minute
washes in PBS to restore neutrality. Cells were incubated in 20% rat serum/TBST
for 10 minutes, and then incubated with purified monoclonal rat anti-BrdU IgG-
direct peroxidase conjugate (Roche) diluted 1:10 in 20% rat serum/TBST for 1 hour.
Negative control slides omitted the primary antibody. Positively stained nuclei were
visualised by Liquid DAB Chromogen with DAB enhancer (Biogenex), used
according to the manufacturer's instructions. Slides were counterstained with
haematoxylin, mounted, and coverslipped.
2.1.8. Flow cytometric evaluation ofcell proliferation
Fresh lung tissue was collected, disaggregated and nuclei stained by propidium
iodide as described by Vindelov (1985). This method produces clean, single nuclei
essentially devoid of residual cytoplasm. Ten thousand nuclei from each sample
were analysed for DNA content by a Coulter EPICS CS flow cytometer, measuring
fluorescence emitted by each nucleus at 610nm (red fluorescence) in 488nm Argon
laser light. The gate was set to red fluorescence and the results of each analysis were
viewed as a histogram of recorded red fluorescent events. The total red fluorescence
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emitted by each nucleus is proportional to the amount of bound propidium iodide.
Propidium iodide binds stoichiometrically to DNA hence the integral red
fluorescence recorded by the flow cytometer for each nucleus is proportional to DNA
content. The histograms of red fluorescence are therefore histograms of nuclear
DNA content.
2. l.h. Ribonuclease protection assays
Total RNA was extracted from frozen tissues using TriGene (Sigma) according to
the manufacturer's instructions. Quantitative determination of RNA yield was
accomplished by spectrophotometry in a 70pl cuvette (GeneQuant, Pharmacia
Biotech). Quality of RNA was assessed by visualisation of Ethidium Bromide-
stained extracts electrophoresed on a formaldehyde gel. Streaking of ribosomal
RNA bands was considered indicative of degradation.
Generation of radiolabeled antisense riboprobes was accomplished with the use of
RiboQuant™ MultiProbe mAPO-2 Template Set (Pharmingen) and In Vitro
Transcription (Pharmingen) kits, in accordance with manufacturer's instructions.
Riboprobe templates are transcribed from pPMG plasmids containing the gene
fragment of interest, in this case, members of the bcl-2 family and housekeeping
genes L32 and GAPDH. Transcription from SP6 promoters produce sense
riboprobes, whilst polymerisation from T7 promoters generates antisense probes.
Templates were transcribed with T7 polymerase in the presence of an excess of P-
dUTP (32030X, ICN) for 1 hour at 37°C, in accordance with manufacturer's
instructions. Subsequent incubation with DNase I removed plasmid templates, and
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thus allowed purification of riboprobes. Riboprobes were purified by stepwise
phenol:chloroform extraction and ammonium acetate/absolute ethanol precipitation,
in accordance with manufacturer's instructions. The RNA pellet was air dried and
dissolved in 50pl hybridisation buffer (Pharmingen). Counts/min of dissolved
riboprobe were analysed in a scintillation counter (LKB Wallac). The acceptable
minimum was 3x105 counts/min.
20pg RNA extracts in 1.5 ml eppendorf tubes were vacuum-dried and redissolved in
8pl hybridisation buffer (Pharmingen). 2pl probe (diluted between 2.3-4.3x105
counts/min) was added to each sample. Samples were covered with nuclease-free
mineral oil, centrifuged briefly, and removed to a heat block at 90°C. Heat block
was immediately reduced to 56°C and maintained at this temperature overnight to
allow hybridisation.
The following day, eppendorfs were removed to a 30°C water bath for 15 minutes
prior to RNase treatment. A mixture of RNase A and T1 in an appropriate buffer
(Pharmingen) was incubated with each sample for 45 minutes at 30°C to digest
single-stranded RNA. Double-stranded RNA, procured from overnight hybridisation
of total RNA with antisense probes, was purified and resolved by polyacrylamide gel
electrophoresis, in accordance with manufacturer's instructions. Protected probes
were quantified with Phosphorimager apparatus (Fuji), and expressed relative to
housekeeping gene L32.
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2.2. IN VITRO STUDIES
2.2. a. Primary Clara cell culture
The perfusion apparatus was sterilised and cleaned before and after use by running
through 70% absolute ethanol/tissue culture grade water followed by tissue culture
grade water. All reagents and equipment in contact with isolates were cleaned to
tissue culture grade standard and sterilised. Perfusions were carried out under still
air conditions and once Clara cells were isolated all subsequent handling was
performed in a sterile laminar flow tissue culture hood (Class II) using sterile
technique. The Clara cell isolation and culture method is summarized in Figure 2.2.
2.2.a.l. Dissection and lavage of lung
Young adult mice were given a lethal intraperitoneal injection of 0.2 ml Sagatal. The
ventral surface skin was removed and the midline incised to allow entry into the
peritoneal cavity. The gastrointestinal tract was displaced to the right and the major
dorsal blood vessels severed, thus achieving exsanguination. The thyroid gland was
excised allowing entry to the trachea. The trachea was separated from the underlying
oesophagus and cannulated (1mm Luer cannula, CAN 1004, Scientific Lab Supplies).
The diaphragm was opened via an incision at the caudal-most aspect of the
xiphisternum. The rib cage was removed followed by a portion of thymus,
facilitating ease of access to the myocardium. Care was taken not to puncture the
lungs. A haemostat was attached to the apex of the myocardium and rotated 180
degrees counter-clockwise, facilitating entry into the right ventricle. The right
ventricle was incised perpendicular to the right coronary artery, and a cannula
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Figure 2.2. Clara cell isolation method and culture method. A) The 1st catheter
is inserted into the trachea and used to extract BAL fluid. B) The 2nd catheter is
inserted into the right ventricle of the heart and used to lavage the pulmonary
circulation with ice-cold saline. C) Trypsin is administered to the lungs in situ
via the trachea (1st catheter). D) Intact lungs are harvested and removed to a
37°C water bath to facilitate digestion. E) Lungs are minced and filtered
through a 100pm mesh. Low centrifuge spins (30xG) removes blood cells and
selects for bronchiolar clumps. F) Macrophages and fibroblasts are removed
by differential attachment to charged plastic. G) Isolated bronchiolar cell
clumps are washed in PBS, resuspended in pre-warmed medium (37°C) and
seeded to fibronectin-coated slides.
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(1.7mm Luer cannula, CAN1008, Scientific Lab Supplies) inserted through the semi¬
lunar valve into the pulmonary artery. Sterile saline (0.15M NaCl) was gravity fed
through the cannula, causing expansion of the left atrium. An incision was made in
the left atrium to allow fluid exit. Lungs were artificially ventilated with a 1.0ml
syringe of air. After 5 ventilations, the lungs were largely devoid of blood, and
appeared white. Intracardial cannula was removed and discarded.
2.2.a.2. Digestion and removal of lung
Ice-cold trypsin was intratracheally instilled into the lungs in situ via the remaining
cannula. Myocardium was removed and phrenic nerve, oesophagus, posterior vena
cava, and strands of mediastinum severed, allowing detachment of the lungs from the
peritoneal cavity. Trachea was severed rostral to the insertion point of the cannula
and the lungs and trachea, with syringe and cannula attached, removed to a vial of
PBS preheated to 37°C. The plunged syringe, necessary to minimise leakage of
trypsin throughout the dissection, was at this point discarded. Trypsin-instilled lungs
were incubated for 10 minutes at 37°C.
2.2.a.3. Cell purification by centrifugation
Trypsinised lungs were removed to a sterile plastic tissue culture dish and minced to
1/4 mm diameter portions with sterile scissors. Foetal Bovine Serum (2mls/lung) was
added to shredded tissue to inhibit further trypsin activity. Shredded tissue was
transferred to a 50ml centrifuge tube, diluted 1:1 with DNase I solution, and hand-
shaken for 4 minutes. Treatment with DNase I reduced viscousity. Clumps of tissue
were removed by passing preparation through a 100pm mesh gauze. Low centrifuge
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spins (30g) in ice-cold PBS removed remaining blood cells and selected for
bronchiolar cell clumps. Pellets, devoid of erythrocytes and thus white, were
resuspended in lOmls medium (5% FBS) and plated onto a sterile plastic tissue
culture dish at 37°C, 5%C02/air for 90 minutes, to allow differential attachment.
2.2.a.4. Cell purification by differential attachment
At this point in the procedure, the isolate consists predominantly of bronchiolar cell
clumps, with typical 'bunch of grapes' morphology, but also macrophages and
fibroblasts. The latter two cell types have an increased capacity to adhere to charged
plastic than epithelial cell clumps. Serum was added to the medium to promote the
adhesion of non-parenchymal cells.
Isolates were incubated at 37°C, 5%C02/air in 5% FBS medium for 90 minutes to
allow non-parenchymal cells to attach. Supernatants were collected into 50ml tubes
and centrifuged at lOOg for 10 minutes. Pellets were washed in PBS and
resuspended in 1ml serum-free medium. A lOpl aliquot was taken for an
approximate cell count (see 2.c.l). Suspensions were diluted accordingly and seeded
to fibronectin-coated chamber slides. Cells were maintained in serum-free
conditions in 5% C02/air at 37°C unless otherwise stated. Fresh medium was
introduced every 24 hours.
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2.2.a.5. Plating of freshly isolated Clara cells
It is a standard practice to evaluate the yield of isolated cells using a
haemocytometer. However, the latter apparatus is designed primarily for quantifying
single cell suspensions and not clumps of adherent cells. Instead, aggregates of Clara
cell isolates with typical 'bunch of grapes' morphology were counted using the
haemocytometer, and diluted to approximately of lxl04 clumps/ml in serum-free
medium. 400pl Clara cell suspension was seeded to each well of Lab Tek II 8-well
chamber slides. 3ml Clara cell suspension was seeded to each chamber flask.
2.2.a.6. Cell substratum
Clara cells were cultured on fibronectin-coated glass. Clara cells do not attach
readily to charged plastic hence non-charged glass chamber slides and flasks were
used throughout. Glass flasks were adapted for use with the Leica videomicroscope
via the addition of a glass platform, sandwiched between the chamber flask and
videomicroscope moveable platform.
Glass chamber slides (Lab-Tek™ II, Life Technologies) and flasks (Flaskette, Life
Technologies) were coated overnight with fibronectin (Sigma), diluted lOpg/ml in
PBS, at 4°C. 30 minutes prior to plating, slides and flasks were washed in PBS and
allowed to air-dry in a Class II tissue culture hood.
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2.2.a.7. Culture medium
Medium formulation is a major determinant of both culture survival and maintenance
of in vivo phenotype. Serum-free medium is desirable because serum is undefined
and promotes growth of non-parenchymal cells. The medium used throughout the
isolation and culture procedure was a 1:1 mixture of Hams F12 (GIBCO) and M-199
medium (GIBCO) with supplements. Supplements included the amino acid
glutamine, the antibiotics penicllin and streptomycin, the non-haem iron-transport
protein transferrin, the strerol hydrocortisione, the retinol derivative retinyl acetate,
and insulin and epidermal growth factors. This medium composition is a derivation
of the formula used previously by Masek & Richards (1990) and is identical to that
used by McBride and others (2000) in the primary culture of murine Clara cells.




IX Insulin/Transferrin/Selenium (ITS-X, GIBCO)
lOng/ml Hydrocortisone (Sigma)
O.lng/ml Retinyl Acetate (Sigma)
lOng/ml Epidermal Growth Factor (rhEGF, Sigma)
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2.2.b. Morphology
Clara cell cultures from wild type and p53-/- mice were stained with
haematoxylin/methyl green and assessed for morphological abnormalities by light
microscopy.
2.2.c. Immunocvtochemistry
2.2.C.I. Clara cell lOkDa protein (CC10)
Cultures plated onto Lab Tek II Glass chamber slides were fixed overnight at 4°C in
80% ethanol/PBS. Slides were incubated with CC10 rabbit polyclonal IgG (courtesy
of S. O'Dea), diluted 1:100 in 20% swine serum/PBS for 1 hour. Slides were
washed in PBS and incubated with biotinylated swine anti-rabbit IgG, diluted 1:500
in 20% swine serum/PBS. Avidin-biotin alkaline phosphatase complex (Dako) was
the final labeling agent and the chromogen was Vector Blue (Vector Laboratories).
Nuclei were Feulgen counterstained, mounted, and coverslipped. Negative controls
omitted primary antibody.
2.2.C.2. 5-Bromo-2'-deoxyuridine (BrdU)
Cultures plated onto Lab Tek II Glass chamber slides were exposed to medium
containing 40pM BrdU for 24 hours, after which they were fixed overnight at 4°C in
80% ethanol/PBS. Cells that had incorporated BrdU into DNA were labelled by
direct peroxidase immunocytochemistry, as described previously (section l.f.4).
Slides were counterstained with haematoxylin and light green, mounted, and
coverslipped.
84
Evaluation of BrdU positivity in primary Clara cell culture was accomplished by
AxioHOME microscopy. 500 Clara cells (sufficient to achieve a stable running
mean) were counted from at least seven randomly selected fields and the results
expressed as a percentage (BrdU labelling index).
2.2.C.3. Pericentrin
Cultures plated onto Lab Tek II chamber slides were fixed in ice-cold methanol for
10 minutes, air-dried, washed in PBS (3x5mins), and blocked in 3% Bovine Serum
Albumin in PBS. Slides were incubated with rabbit anti-pericentrin IgG (BAbCO),
diluted 1:100 in 3% BSA/PBS, overnight at 4°C. Slides were washed in PBS
(3x5mins) and incubated with FITC-conjugated swine anti-rabbit secondary antibody
(Dako), diluted 1:20 in 3% BSA/PBS, for 1 hour at room temperature. Nuclei were
counterstained with propidium iodide, mounted, and coverslipped. Staining was
visualised by Confocal Microscopy.
Evaluation of centrosome number was accomplished by Confocal microscopy. 300
Clara cells (sufficient to achieve a stable running mean) were counted from five high
power randomly selected fields and the results expressed as a percentage.
2.2.d. Irradiation
After 48 hours in culture, Clara cells were 5 Gray y-irradiated by a Cs-137 source at




Cultures plated onto glass chamber flasks were subjected to time-lapse
videomicroscopy for a period of 24 hours. Cultures were gassed with 5%C02/Air
prior to their insertion onto the videomicroscope moveable platform (Leica).
Cultures and microscope apparatus were maintained at 37°C throughout the analysis.
Digital images were taken from 5 fields per flask every 15 minutes with the
videomicroscope (Leica) and associated software (QUIPS, Leica). Images pooled
from the resultant succession of TIFF files (Microsoft) were converted to GIF files
(Microsoft) for video analysis (GIF animator, Microsoft). Videos were analysed
blind for abnormal mitosis and cytokinesis events.
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2.3. CHARACTERISATION OF SP-C/Cre TRANSGENIC MICE
2.3. a. Subclonins
2.3.a.1. Agarose Gel Electrophoresis of DNA
The agarose gel concentration used was dependent on the size of the DNA molecules
to be resolved. TBE gels were prepared in accordance with Standard Operating
Procedures. Samples to be run were mixed with loading buffer and loaded directly
onto the gel. Molecular weight markers (1 kb Ladder, Life Technologies) were
diluted in loading buffer and used where appropriate. Electrophoresis was
accomplished in IX TBE at 50-100V.
2.3.a.2. Restriction Digest Analysis of Plasmid DNA
A suitable amount of DNA was mixed with 0. 1 volumes of 1 OX reaction buffer
(supplied by the manufacturer) and 0.1 volumes of 10X Bovine Serum Albumin as
required (manufacturer's instructions). 0.1 volumes of restriction endonuclease were
added to the reaction mix and any remaining volume was made up to 50pl with
ddH20. The digests were incubated for l~24hrs at the temperature recommended by
the manufacturer (New England Biolabs). Digested fragments were visualised on
agarose gels.
2.3.a.3. Extraction of DNA Fragments from Agarose Gels
The QIAEX H Gel Extraction Kit (QIAGEN) was used for the purification of DNA
fragments from agarose gels. DNA was digested with appropriate restriction
endonucleases and electrophoresed on an agarose-TBE gel containing ethidium
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bromide. The bands were visualised with UV light (Herolab, gel documentation
equipment) and excised from the gel with a scalpel. The gel slice was weighed and
appropriate volumes of solubilisation buffer and DNA-binding resin were added to
the sample according to the manufacturers instructions. Following solubilisation and
adsorption of the DNA to the resin, the sample was centrifuged at 10,000g for 30
seconds. The resin pellet was washed three times and air-dried for 15 minutes. To
elute the DNA, the pellet was resuspended in 20pl of water. DNA samples extracted
from gels in this manner were stored at -20°C.
2.3.a.4. DNA Ligation
Purified DNA fragments encoding SP-C/Cre were ligated into bluescript plasmid to
facilitate the manufacture of probes for Southern analysis. pBS was linearised, and
subsequently dephosphorylated with Shrimp Alkaline Phosphatase (SAP, United
States Biochemical). SAP removed 5' terminal phosphate groups from linearised
DNA and thus prevented vector recircularisation in ligation reactions. SAP reaction
was accomplished in the presence of 0.1 volumes of 10X SAP reaction buffer for 30
minutes at 37°C. 1 unit SAP was used per reaction.
It is crucial to ensure that all SAP activity is removed before a treated DNA sample
is used in a ligation reaction otherwise other reaction components could also be
dephosphorylated preventing efficient ligation. This was achieved by incubation of
SAP reaction mixtures at 65°C for 10 minutes.
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Equal ratios of insert and SAP-treated vector were mixed together for the ligation
reaction. The total volume of reaction mix was 20 pi. This was then added directly
into a tube of dehydrated Ready-To-Go™ T4 DNA ligase (Pharmacia Biotech). The
ligation reaction was incubated at room temperature for 5 minutes, mixed by gentle
pipetting and then transferred to a 16°C water bath for 30 minutes. After this time
the ligation is complete. T4 DNA ligase was inactivated by heating to 70°C for 10
minutes. The sample was then used to transform bacteria.
2.3.a.5. Transformation of Bacteria With Plasmid DNA
A 5 pi aliquot of Epicurian Coli XL-2 Blue ultracompetent cells (5 x 109 cfu/ug
pUC18 DNA, Stratagene) was removed from storage at -70°C and thawed on ice.
Plasmid DNA was added directly onto the cells and then mixed by pipeting. The
cells and the DNA were incubated on ice for 30 minutes, heat shocked at 42°C for 45
seconds and returned to ice for a further 2 minutes. 80pl Luria Broth (LB) was
added to the tube, which was then incubated at 37°C for 1 hour in an orbital
incubator at 225rpm. The transformed bacteria were plated onto LB-agar plates
containing appropriate antibiotics that selected for transformants.
2.3.a.6. Preparation of Plasmid DNA
Plasmid DNA was purified from transformed E. coli with QIAGEN Miniprep and
Maxiprep kits, the kit used determined by the yield required. Both procedures are
similar, and were accomplished in accordance with the manufacturer's instructions.
Briefly, bacterial pellets are resuspended in Tris-HCl/EDTA and RNase A is added
to this solution to avoid RNA contamination in later nucleic acid purification steps.
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Bacterial lysis is accomplished by exposing suspensions to a mixture of NaOH and
SDS. The lysis reaction is subsequently neutralised by addition of potassium acetate.
This latter step produces a protein precipitate, subsequently removed by
centrifugation. Supernatants were transferred to fresh eppendorfs, and the DNA
purified by stepwise phenohchloroform extraction, isopropanol precipitation, partial
rehydration in 70% ethanol, and dissolved in TE pH 8.0. Plasmid DNA was stored at
-20°C.
This "miniprep" method is a modification of the procedures described in Sambrook
et al. (Sambrook et al, 1989). A single bacterial clone was picked from a LB-agar
plate using a sterile p200 pipette tip. The clone was transferred to a Falcon 2059
tube containing 5 ml of LB supplemented with appropriate antibiotics and incubated
in an orbital incubator (225rpm) at 37C overnight. The following day, bacterial
pellets were harvested by centrifugation.
Large-scale isolation of plasmid DNA was carried out using a Plasmid Maxi Kit
(QIAGEN) according to the manufacturer's instructions. A flask containing 100ml
of LB, supplemented with the appropriate antibiotics, was inoculated with bacteria
from suitable miniprep cultures. The bacteria were grown for 12- 16 hours in an
orbital incubator, harvested by centrifugation (4,000rpm for 10 minutes at 4°C,
Sorvall GSA rotor, Centrikon H-40IB), resuspended and lysed just as for the
miniprep method. Protein precipitate was removed by centrifugation at ll,500rpm
for 30 minutes at 4°C (Sorvall GSA rotor, Centrikon H-401B). The need for an
organic extraction was avoided by use of QIAGEN-tips with a DNA-binding resin.
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Supernatants were added directly to QIAGEN-tips. QIAGEN-tip columns with
bound DNA were washed twice prior to elution of DNA. DNA was precipitated,
rehydrated, and dissolved in TE, in accordance with manufacturer's instructions.
2.3.b. Southern Blotting
2.3.b.l. Preparation of DNA
10 pg of genomic DNA was digested with an appropriate restriction enzyme.
Following digestion, the entire sample was electrophoresed on a 0.8% gel at low
voltage (40V) until dye front had reached the distal most aspect of the gel.
Fragments of interest were predicted to be larger than 15kb, hence transfer of the
DNA to the nylon membrane was improved by partially depurination ('acid nick') of
the DNA prior to transfer. Depurination was achieved by soaking the gel for 10
minutes 0.2M HCI. The gel was then rinsed in deionised water and the DNA was
transferred immediately.
2.3.b.2. DNA Transfer
DNA was transferred from the gel onto a positively charged nylon membrane, Zeta-
Probe® GT, Bio-Rad) according to the manufacturers instructions. 0.4M sodium
hydroxide was used as the transfer buffer. Blotting was accomplished overnight.
The membrane was subsequently rinsed in 2XSSC, air-dried, and baked in vacuo at
80°C for 30 minutes. Membranes were stored between sheets of Whatman 3MM
paper at room temperature until required.
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2.3.b.3. Prehybridisation
Hybridisation buffer was preheated to 68°C to ensure complete all components were
in solution. lOmls buffer was transferred to a hybridisation tube (Hybaid) containing
the baked nylon membrane to allow the membrane to equilibrate. Membrane and
buffer were incubated at 68°C for 1 hour in a hybridisation oven (Hybaid).
2.3.b.4. Generation of Radiolabelled Probes
50ng of appropriate DNA was radiolabelled to a high specificity with 32P-dCTP.
Labelling was accomplished with Ready-To-Go T4 DNA polymerase beads, in
accordance with manufacturer's instructions. Labelled probe was separated from
unincorporated nucleotides using a Sephadex G50 column (Pharmacia). 20pl carrier
salmon sperm DNA (lOmg/ml) was mixed with radiolabelled material prior to
addition to column. Unincorporated nucleotides were eluted by addition of 400pl TE
buffer. The addition of a further 400pl TE eluted the purified probe. Quality of
radiolabelling was assessed by comparison of the counts/minute of both elution
products. Labelled probe was only used if it had incorporated >50%
radionucleotides.
2.3.b.5. Hybridisation
Following prehybridisation, radiolabelled probe was added to the hybridisation tube.
The membrane was incubated with the radiolabelled probe in hybridisation buffer
overnight at 68°C. Subsequently, the membrane was washed in solutions of
increasing stringency, removed from the hybridisation tube, sealed in a plastic bag,
and exposed to Hyperfilm (Amersham) in an autoradiography cassette. Cassettes
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were incubated at -70°C for 2-5 days. Autoradiography films were subsequently
developed (Hyperprocessor, Amersham).
2.3.c. PCR Strategies
2.3.C.I. Genomic PCR Strategies
PCR strategies were accomplished using RedTaqIM DNA polymerase (Sigma) and
accompanying reaction buffer. Magnesium chloride (llmM) and potassium
chloride (500mM) were included in RedTaq™ buffer at 10X stock concentrations.
Pharmacia Biotech supplied all deoxyribonucleoside-triphosphates (dNTPs).
Oligonucleotides were synthesised by Cruachem. PCR reactions were accomplished
in a thermocycler (Hybaid), PCR products were analysed on agarose gels.
Conditions in which PCR was accomplished are summarised in Table 2.3:
2.3.C.2. RT-PCR Strategies
An appropriate amount of RNA was diluted in a total volume of 11 pi with nuclease-
free water and lpl of oligo dT primer (500ug/ml, Cruachem). The sample was
heated to 70°C for 10 minutes then transferred onto ice. After 1 minute on ice, a
further 4pl of 5X First Strand Buffer, 2pl of 0.1M Dithiothreitol and 2pl of dNTP
mix (lOmM) was added. The samples were mixed and heated to 42°C for 2 minutes.
lul (200 Units) of Superscript1M II RNase H-Reverse Transcriptase was added to
each tube. Reactions were allowed to proceed at 42°C for a further 50 minutes, by
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TABLE 2.3 - PCR Protocols
PCR Primers

















Meltins Annealins Extension Cycles
Cre660
P-actin
94°C, 45 sec 55°C, 1 min 72°C, 1 min
94°C, 45 sec 55°C, 1 min 72°C, 1 min
Ligl genotyping 94°C, 40 sec 65°C, 1 min 72°C, 1 min






which time cDNA synthesis is complete. Reverse transcriptase enzyme was heat
inactivated by a 15 minute incubation at 70°C.
PCR of mouse (3-actin and Cre recombinase cDNAs was accomplished in conditions
summarised in Table 2.3:
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3. Results
3.1. The Role of p53 in the Lung
3.1.a. DNA Damage Response of Small Airway Epithelial Cells
3.1.a.l. Induction of p53 in bronchioalveolar cells
In an initial experiment, Balb/c mice were treated with a range of DNA-damaging
agents to determine their ability to elicit p53 stabilisation in lung epithelial cells.
Mice were treated with the methylating agent MNNG, which induces O6-
methylguanine lesions and other types of base damage, the crosslinking agent
nitrogen mustard, which induces bulky adduct formation requiring nucleotide
excision repair, and ionizing radiation, which induces DNA strand breaks. Lungs
were harvested at 6 hours post-insult, processed as described in materials and
methods (section 2.1), and subjected to SDS-PAGE for p53 protein analysis. The
lungs of Balb/c mice displayed a rapid 3-fold increase in p53 protein by 6 hours
following MNNG, N2M, and IR treatment, as determined by SDS-PAGE of total
protein extracts (150pg protein/well)(Figure 3.1.i). The level of p53 stabilisation in
damaged lungs was similar between the different treatments, but was low relative to
irradiated spleen, where only 20pg of protein was loaded (Figure 3.1 .i).
To more accurately monitor induction of p53 in DNA-damaged lung, a timecourse of
p53 stabilisation following 5 Gray y-irradiation was assessed in Balb/c mice by CM5
immunohistochemistry. p53 protein was detected in the nuclei of both ciliated cells
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Densitometryofp53Western
Figure3.1.iInductionofp53inai wayepith li lel s
A)Westernblotanalysisofp53express oni whole-lungt inextractspreparedfromun reated(UN),y-ir diatedIR ,m thylatingg t (MNNG),andlkylatinggent( 2M)treatedmice.Ar pidincr sep53ro einwasobs rvedimou elungsby6h urfo l wingxposure DNA-damagingagents,sdeterminedbydensitometry(opt cald nsity= t gratedopticaldensit /numberfix lsthreshold de,MetaMo ph version4.5,UniversalImagingc.)Proteextractsf mir ad tedpleen(SP)rvedap sitivec rol.M anp cald sity(n=2)fallu g proteinextractswere14(UN),42IR3(M NG)and40.5(N M). B-C)p53-Immunoperoxidasestainingofparaformaldehyde-fixedtissuect o s.Im nop sitivecl i( r ws)w rbs dbr nchiolarc ll (B)andsplenocytesC)ofirr diatedmi(4h urpost-insult).
and non-ciliated cells of the bronchioles (Figure 3.1.i). Increased staining of p53 was
observed by immunohistochemistry from the earliest timepoint of 2 hours and was
maintained until the latest timepoint of 48 hours. p53 protein was additionally
observed in irradiated cells of the spleen, but not the liver, as reported previously
(Midgley et ah, 1995).
3.1.a.2. Bax and Bcl-x, but not p2iWAF1/clF1 proteins are expressed in bronchiolar
epithelial cells
To determine additional effects of DNA damage in small airway epithelium,
expression analysis of the candidate p53 stress-response genes Bax, Bcl-x, and p21
was accomplished in irradiated and unirradiated mouse lungs. In the mouse, three
splice isoforms of Bax have as yet been reported (Krajewski et ah, 1994). The most
common transcript encodes a 21kDa protein that topographically resembles the Bcl-2
protein by virtue of the presence of a transmembrane domain. Expression of the Bax
21kDa isoform is associated with apoptosis in certain cell types. The other reported
variants of Bax include 24kDa and 5kDa isoforms, both lacking the transmembrane
domain. Their function is unknown, but is distinct from apoptosis (Krajewski et al.,
1994). P-19, the antibody used in this analysis, recognised a region conserved
between the three isoforms of Bax.
The only Bax isoform detected in murine lung was the 21kDa protein. Bax was
detected in the lungs of untreated mice, and did not display induction following
irradiation, as demonstrated by SDS-PAGE. (Figure 3.l.ii). Bax protein localised to
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Figure3.1.iiExpressionofBax,cl-xandp21inirwayep thelialel s
A)WesternblotanalysisofB x,cl-xL/sndp21WAF1/CIP1expres ioniwhole-lungrottractprep redfr mun ea(UN)y-irradiate mice(4and2hourspost-irradiation).MilinductiofBax,bnotcl-xL/sp21WAF1/CIP1rot ins,w sb ervedirr d tm u elu g
E)Bronchiolarcel simmu ohist chemicallylab lledw tax(yel w)anBcl-xL/sbrownantibodiesu reat dB,Di radiateC Em u e lungs.Labellingwascytoplasmici columnarepitheliumandddit o allyobs rvedCla llsecr t sfirradi emou elung( rr w , C,E).p21WAF1/CIP1expressionwasobs rvedinalv olarc l sfirradi tmou elu g( ,ns t),buexpre ionw akrel tivett tin l villi(G).p21WAF,/CIP1expressionwasnotobs rvedibro chiolarepithe iuma ltimpoints.
bronchiolar epithelium, additionally a site of p53 stabilisation, and was observed
within Clara cell secretions (Figure 3.1.ii).
Two major splice isoforms of the Bcl-x locus exist. M-125, the antibody used in this
analysis, recognises an amino terminus epitope conserved between the long and short
isoforms. Both protein isoforms were constitutively expressed in murine lung and
did not increase following DNA damage, as demonstrated by SDS-PAGE (Figure
3c). Immunohistochemical analysis with M-125 revealed constitutive Bcl-x175
expression in columnar epithelium (Figure 3.1.ii). Bcl-x175 expression was
additionally observed in Clara cell secretions (Figure 3.1.ii).
The CDK inhibitor p2iWAF1/CIP1 has been implicated in DNA damage-induced G1
growth arrest (Brugarolos et al., 1995; El-Deiry et al., 1994; Waga et al., 1994; Li et
al., 1994). Transcriptional upregulation of p2iWAF1/clP1 in the lung in response to
ionizing radiation has been documented previously (Macleod et al., 1995). In this
analysis, regulation of p21 WAF1/CIP1 was assessed at the protein level. p21 WAF1/CIP1
expression levels were similar in the lungs of unirradiated and irradiated Balb/c mice,
as determined by SDS-PAGE analysis of total protein extracts (Figure 3.1.ii).
Immunohistochemical analysis revealed that p2iWAF1/clP1 expression was localised to
alveolar epithelial cells of the small airways, and was not observed in bronchiolar
epithelium (Figure 3.1.ii). Staining was nuclear in irradiated alveolar cells, but was
weak in comparison to intestinal epithelial cells, where a role of p21 WAF1/CIP1 in the
induction and maintenance of terminal differentiation has been documented
previously (Doglioni et al., 1996; Sasaki et al., 1996).
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3.1.a.3. Radiation induces DNA strand breaks, but not apoptosis in lung epithelium
To more accurately determine the effects of DNA damage in small airway
epithelium, analysis of gene expression in murine lungs was supplemented with
morphometric analysis of proliferation and apoptosis. Cell cycle activity was
assessed in the lung by bromodeoxyuridine (BrdU) incorporation. Intestine
harvested from BrdU-treated animals served as a comparison. Epithelial cells of the
intestinal crypts incorporated BrdU (Figure 3.1 .iii), consistent with documented cell
proliferation in the gut (Clarke et al., 1994). By contrast, lung epithelial cells did not
incorporate BrdU prior to and following irradiation, and thus were unlikely to be
proliferating. Vindelov flow cytometry analysis confirmed these findings and
demonstrated that > 95% of lung tissue was G0/G1 growth arrested prior to
irradiation exposure (Figure 3.1.iii).
Two methods, TUNEL and morphology, were compared in their ability to detect
apoptosis on paraffin sections of damaged lung. TUNEL is a method for detecting
DNA strand breaks in situ. DNA strand breaks are not exclusively a feature of
apoptotic cells, but also occur in damaged and necrotic cells (Grasl-Kraupp et al.,
1995). TUNEL staining was observed in small airway epithelial cells following
radiation insult, but the staining was titratable and required a high concentration of
TdT in the TUNEL reaction (Figure 3.1.iv). Apoptotic splenocytes, by contrast,
remained TUNEL positive in reduced TdT concentrations. TUNEL was thus a poor
surrogate method for the detection of apoptosis in lung epithelium. The incidence of
apoptosis was more accurately determined by morphology on haematoxylin and
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regardless of genotype. Apoptosis was observed in lymphoid cells upon irradiation
as reported previously (Malcolmson et al., 1997). Significantly, lymphoid cell
apoptosis was absent in lungs of p53-deficient animals. Apoptosis was observed in a
few scattered endothelial components of irradiated lung and mediastinum. Typically,
counts per field of view were less than 1 per cent.
3.1.b. Trans-modulatory effects of p53 in irradiated lung
To more accurately determine transactivation functions of p53, Ribonuclease
Protection Assays were used to determine the abundance of bcl-2 family transcripts
over a 48 hour timecourse following irradiation. The lungs of gene-targeted mice,
germline deficient in p53, were harvested at 0, 2, 4, 8, 24, and 48 hours following
irradiation and compared to those of wild-type controls. In the lungs of untreated
animals, bcl-2 family mRNA profiles were similar regardless of genotype. Induction
of the death-related gene Bax was observed in response to DNA damage (Figure
3.1.v-vi). Wild type animals displayed a twofold increase in Bax mRNA from 4
hours post-injury, and Bax expression levels remained significantly greater than that
of untreated animals at the later timepoint of 8 hours. The lungs of p53 -/- littermates
did not display this rapid induction of Bax mRNA, and over the 48 hours following






















































Figure3.1.vRNaseProtectionAss yofBcl-2family expression A)RepresentativeRPAdisplayingdetectablelev lsofBcl-xL,Bcl-xS,anB x mRNAtranscriptsover48hourtimecourse.Undigestedprobes(left)s rvedas sizemarkers.B)TablesummarisingdataobtainedfromRPAdensitometry analysisofwildtypeandp53-deficientmouselung(seeMaterialsndMethods). mRNAscores(e.g.Bax/L32)reexpres edrel tivetounirradiat dcontr ls.Data representsthmean(n=3)±standarddevia ion(forcomple edats t,see appendix).
Hourspost-irradiationH lmpost.irradiationHop st-irradiation Figure3.1.viRNasProtectionAssayfBcl-2familexpressio Graphssummarisingthed tpres ntedinFigur3.1.v.Asterisk(*)acknowledge statisticallyignificantdifferen esinBcl-2familym mb rRNAabu dancerelativto L32mRNA,asdeterminedbyone-tailt st(P<0.05).F rco pletets , appendix.
A decrease in abundance of the Bcl-x short isoform mRNA was observed in
irradiated lungs of wild type mice (Figure 3.1.v-vi). From 2 hours following
irradiation, Bcl-x transcripts were approximately one third of that of unirradiated
controls, and these reduced expression levels were maintained until the latest
timepoint considered of 48 hours. p53-/- mice did not display this reduction in Bel-
x transcripts following radiation, but instead showed a steady induction of Bcl-x
mRNA over this 48 hour timecourse when compared with unirradiated controls. Bel-
o
x mRNA expression levels in p53-/- mice were at their maximal (80% increase
relative to unirradiated controls) at the latest timepoint considered of 48 hours
following irradiation.
The other family members, Bcl-w, Bfl-1, Bak, and Bcl-2 did not show altered
regulation upon DNA damage. Constitutive expression of Bcl-xL transcripts was
observed at all timepoints, which was variable between individual mice but did not
vary significantly between genotypes (Figure 3.1.v-vi).
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3.1.c. Effects of p53-deficiericy in Primary Clara cell culture
The effects of p53-deficiency were additionally investigated in short-term primary
cultures of bronchiolar Clara cells. Clara cells, isolated from gene-targeted p53-
deficient mice, were compared to cells derived from wild type littermates. The
isolation and culture method used represents an adaptation of the method described
by Richards. Briefly, mice were killed, lungs lavaged and intratracheally perfused in
situ with trypsin, harvested, and incubated at 37°C in PBS for 10 mins.
Subsequently, lungs were minced to 1/4 mm diameter portions and passed through a
lOOmicron mesh. Low centrifuge spins (30G) removed blood cells and selected for
bronchiolar cell clumps. Macrophages and fibroblasts were removed by differential
attachment to charged plastic. Isolated bronchiolar cell clumps were washed in PBS,
and seeded to fibronectin-coated chamber slides. Clara cells, identified by
histochemical markers, were maintained in serum-free conditions unless otherwise
stated.
3.I.C.I. Morphological abnormalities in p53-deficient Clara cells
Prior to isolation for culture from adult lung, virtually all bronchiolar cells are in the
GO phase. They are thus effectively synchronised before receiving the proliferative
stimulus of isolation and primary culture. In culture, both wild type and p53 null
Clara cells displayed a rise in BrdU positivity from near zero at plating to a peak at
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and p53 null cells at all timepoints. Thus, wild type and p53 null Clara cells display
similar kinetics of entry from GO to S phase.
From 48 hours in culture, a proportion of p53-/- Clara cells displayed morphological
abnormalities. Specifically, two or more nuclei were frequently observed in p53-/-
cultures. Counts of nuclei/cell (nucleation index) in primary cultures revealed that
multinucleation increased over time in cultures of both genotypes, but was
significantly enhanced in the p53 null cells (Figure 3.1.viii). Multinucleated cells
maintained expression of Clara-cell marker genes and were often BrdU positive
(Figure 3.1.viii). However, multinucleation was not associated with DNA synthesis,
which was similar irrespective of p53 status.
It was hypothesised that multinucleation represents a failure to undergo cytokinesis
in cultured Clara cells. Time-lapse videomicroscopy was employed to assess
cytokinesis abnormalities. p53 null cells displayed an array of mitosis and
cytokinesis abnormalities, including multiple spindle formation (Figure 3.l.ix, for
video, see appendix). By contrast, M phase abnormalities were not observed in wild
type cells. Cell death was infrequently observed in time-lapse videos of both
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3.I.C.2. Centrosome amplification in p53-deflcient Clara cells
The observed role of p53 in mitosis and cytokinesis may reflect a role in regulation
of centrosome number. Centrosomes are essential for the formation of bipolar
spindles and the balanced segregation of chromosomes. Defects in shape, size, and
number of centrosomes are frequently observed in malignant tumours and are
associated with gross genome instability (Pihan et ah, 1998; Lingle et al., 1998). A
role of p53 in maintaining centrosome number has been documented previously
(Fukasawa et al., 1996; Fukasawa et al., 1997).
Centrosome abnormalities were assessed by Confocal Microscopy in Clara cell
primary culture. 72 hour-cultured cells were fixed in methanol and
immunofluorescently stained for pericentrin, a protein specific to the centrosome.
Nuclei were counterstained with propidium iodide. Wild type Clara cells contained
predominantly one or two centrosomes juxtaposed to the nucleus (Figure 3.1.x). By
contrast, > 40% of p53 null cells contained more than two centrosomes (Figure
3.1.x). The presence of multiple centrosomes was observed in interphase, mitotic,
and multinucleated cells (Figure 3.1.x).
Thus, p53 regulates centrosome number, mitotic fidelity, and cytokinesis in primary
cultured Clara cells. This role of p53 is independent of DNA damage and may
represent a novel, constitutive role of p53 in maintaining genome integrity.
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3.I.C.3. Growth arrest abnormalities in p53-deficient Clara cells
In response to DNA damage, cells undergo growth arrest and repair, or apoptosis. In
many cell types, these DNA damage responses are regulated by p53. Wild type and
p53 null Clara cell cultures were gamma-irradiated and their response to injury
documented over 24 hours. BrdU incorporation, a measure of entry into S phase,
decreased substantially in wild type cells following irradiation (Figure 3.1.xi). By
contrast, p53 null cells maintained BrdU indices similar to those of unirradiated
controls. The observed growth arrest in irradiated Clara cells is thus p53-dependent.
Apoptosis was not observed in irradiated wild type and p53 -/- Clara cells, as
monitored by time-lapse videomicroscopy. Apoptosis was not observed in 96 frames
displaying 150-200 cells over a 24 hour period (1 frame every 15 minutes), as
determined by morphology. Consequently, the incidence of apoptosis in irradiated
wild type and p53-/- primary Clara cell cultures over the 24 hour period post-injury
is less than 0.5%.
Response to genotoxic injury can be influenced by extracellular factors including
hormones, cytokines, and unspecified serum factors (Bellamy et al., 1997a). The
addition of serum to the medium was sufficient to abolish DNA-damage mediated
growth arrest in wild type Clara cells, which maintained BrdU indices similar to
those of unirradiated controls (Figure 3.1.xi). In addition, p53-/- cultures, but not
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BrdU index of p53-/- Clara cells was 50% greater when cultured in the presence of
5% foetal bovine serum (70% BrdU incorporation with FBS versus 45% in serum-
free conditions), regardless of radiation injury. The latter observation highlights
synergistic effects of p53 and extracellular factors in Clara cell cycle regulation.
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3.2. CHARACTERISATION OF SP-C/Cre TRANSGENIC MICE
3.2.a. Overview
It was the intention of this project to determine the feasibility of tissue specific Cre-
lox conditional gene targeting in lung epithelial cells of transgenic mice. In
collaboration with Dr. Shirley O'Dea, 3.7kb of the human SP-C promoter was used
to express bacteriophage PI Cre recombinase and thus promote Cre-mediated
recombination specifically in the small airway epithelial cells of transgenic mice.
Floxed DNA Ligase I mice (Floxligl) were employed to determine the function of
SP-C/Cre in vivo (see section 1.6).
0 Cre +ve $ O Cre -ve $ ☆ Flox/FIox DNA Ligase 1
1 Cre +ve $ □ Cre -ve $
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In brief, SP-C/Cre plasmid was Notl/Ndel digested and the resulting 5.1 kb fragment
microinjected into blastocysts and introduced into pseudopregnant recipients to
produce transgenic mice expressing Cre specifically in small airway epithelium. A
single founder mouse was generated which was crossed onto a Floxligl/Floxligl line
to produce Fi mice heterozygous for Floxligl and transgenic for Cre. Three of these
mice were further crossed onto a Floxligl/Floxligl line to generate transgenic animals
hemizygous for Cre, and both heterozygous and homozygous for Floxligl.
Transgene analysis of F2 animals was restricted to Floxligl heterozygotes.
SP-C/Cre was characterised in vivo via analysis of transgene stability and function.
Transgene trans-generation stability was determined by a Southern blot strategy,
whereby resolution of fragments reflected integration sites and concatemerisation of
SP-C/Cre. To facilitate this analysis, an internal probe that labeled a sequence
specific for the human SP-C promoter was required. The human SP-C promoter has
only been partially sequenced, hence restriction mapping and subcloning of the SP-
C/Cre vector was necessary to generate an internal probe suitable for assessing
transgene stability.
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3.2.b. SP-C/Cre Transgene Stability
3.2.b.l. Probe generation
From restriction digest analysis, a novel PstI site lkb upstream of a diagnostic Ncol
site was detected in the human SP-C promoter (Figure 3.2.i). A 1.3kb PstI fragment
(containing the diagnostic Ncol site) was gel-purified and ligated into bluescript
plasmid to facilitate bulk generation of probe (Figure 3.2.ii). Ligations were
transformed into ultracompetent E.coli, plated on X-gal Ampicillin LB plates, and
white colonies picked and cultured overnight in the presence of antibiotics.
Minipreparations of plasmid DNA were purified from aliquots of cultures.
Minipreparations were PstI digested, and resolved by agarose gel electrophoresis to
determine success in ligation and subsequent culture steps. A successful
transformant was cultured overnight in a 100ml flask of medium with antibiotics.
Plasmid DNA was purified to generate 3.3ug yield of subcloned plasmid.
Subcloned plasmid was PstI digested and the 1.3kb fragment gel-purified (Figure
3.2.iii). The latter fragment was further digested with Bstxl to generate 600bp and
700bp fragments. The 700bp fragment did not contain the Ncol site, and hence
encoded the sequence upstream of this restriction site. The 700bp fragment was gel-
















































Figure3.2.iii-Manipulationof theHumanSP-CPro oter GenerationofSP-CPr be The700bpPstl/BstXIfragmentwasel- purifiedandse vesrobetemplat . Probeswereradiolabeledsrequired. GelExtraction of700bpPstl/BstXIfragment
3.2.b.2. SP-C/Cre recombinase transgene is germline stable
Transgene stability was assessed on Southern blots of tail-biopsied DNA. Two
genomic digests, Ncol and Xbal, were employed. Both Ncol and Xbal digest SP-C
downstream of the Bstxl site, and thus downstream of the 700bp probe (Figure
3.2.iv).
Ncol digested DNA of Fo, Fi, F2 mice was electrophoresed on a 0.7 % agarose gel,
blotted onto a nylon membrane, and incubated overnight with radiolabeled SP-C
probe. Autoradiographs of Southern blot displayed two major bands. The
predominant band resolved at 5.5kb, the approximate size of the construct, and
represented multiple copies of the transgene concatemer (Figure 3.2.iv). A larger
band resolving at 7 kb signified a sole integration of the SP-C/Cre transgene into the
mouse genome.
Transgene stability was verified by probing of Xbal digested DNA. SP-C contains
two Xbal sites, and Xba I digestion removes a 428 bp sequence incorporating the
Ncol site. Xbal digested DNA of Fo, Fi, F2 mice was electrophored on a 0.7 %
agarose gel, blotted onto a nylon membrane, and incubated overnight with
radiolabeled SP-C probe. Xba I Southern autoradiographs displayed two distinct
bands (Figure 3.2.iv). The predominant band resolved at 5kb and signified multiple
copies of the transgene concatemer. A single consistent integration band was

























Figure3.2.iv-SouthernanalysisfP-C/Ctransg ns b lity Integrationan lysisoftransgeneco c t mer.A)N olndXbdig tDNAwlect ophor ed,blot ,dincu atei radiolabeledSP-Cpr .t blatternsoftransgin egrationweb rv dfou rmouseprogeny.B)Mo lfSP-C/Crco cat m r basedonSouth rnd ta.
Transgene copy number was quantified via densitometry of the concatemer band
relative to the integration band. In both Ncol and Xbal digests, concatemer band was
threefold more abundant than the integration band. Transgene copy number was thus
low, and contained only three complete copies of the SP-C/Cre construct (Figure
3.2.iv).
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3.2.c. SP-C/Cre Transgene Function
3.2.C.I. Cre mediated recombination is specific to airway epithelium, but infrequent
Excision of the floxed allele was assessed by two methods - PCR and Southern
blotting. PCR amplification of the deleted allele in DNA extracted from a range of
tissues demonstrated Cre-mediated excision in the lung, but not other tissues (Figure
3.2.v, for PCR primers, see Materials and Methods). Cre-mediated excision was thus
specific to lung. Southern blot analysis allowed quantification of the excision event.
A radiolabeled intronic ligase 1 probe encoding a 1.2kb sequence conserved by
floxed, wild-type, and deleted alleles (generated by EcoRI/Hindlll fragment of exons
21-22, courtesy of D.Melton), demonstrated equal densities of floxed and wild-type
alleles in brain, kidney, liver, and lung (Figure 3.2.vi). The deleted allele was not
detected in F| and F2 lung extracts, including those demonstrating excision by PCR.











































Figure3.2.vi-SouthernAnalysisfP-C/Cre-mediat dExcision DNAwasEcoRIdigested,el ctrophoresed,blot ed,andincubatewipan-DNAlig sIr behicrecognisedfloxe ,e ca dwilty alleles.FloxednwitypDNAlig s1ll lrebs rvedintissu sftran g nicmic .ThA i ll ewasotde ect dilu goth r mousetissuesbySouthernlot.
3.2.C.2. Cre expression is not detected in airway epithelium
It was hypothesised that the low level of Cre-mediated recombination in murine lung,
detectable only by PCR amplification, may reflect failure to transcribe Cre. RT-PCR
of Cre and P-actin was performed on total RNA extracted from frozen lung tissue
(Figure 3.2.vii). P-actin expression was observed in all lung extracts, demonstrating
success of the reverse transcription technique. By contrast, Cre cDNAs were not
detected in extracts of reverse transcribed lung total RNA. It is thus unlikely that SP-










Figure3.2.vii-RT-PCRofSP C/ reM sLungs
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4. Discussion
4.1. The Role of p53 in Small Airway Epithelial Cells
Response to DNA damage can be understood in terms of apoptosis, growth arrest,
and expression of genes related to both phenomena. In other cell types, tumour
suppressor p53 is a critical determinant of the response to DNA damage. In this
analysis, the author sought to identify functions of p53 in small airway epithelium.
p53 stabilisation has been observed in the small airways previously, but its
significance is unclear. Because Clara cells are a major progenitor species of the
small airways, and are considered relevant to neoplasia of the lung and centriacinar
emphysema (Massaro et al., 1994), it was hypothesised that phenotypic effects of
p53 deficiency would predominate in this cell type. To discern the role of p53 in the
Clara cell, a method for extracting, isolating, and culturing Clara cells from the
mouse was developed and incorporated into this analysis.
An acute stress response of p53 is documented in mouse small airway epithelium in
vivo, and in isolated Clara cells in vitro. In vivo, p53 stabilisation is observed in
lung epithelium following 5 Gray y-irradiation. Immediate induction of the death-
related gene Bax, but not other bcl-2 transcripts, was p53-dependent following
genotoxic damage. Bax and Bcl-x proteins localise to the columnar epithelium,
additionally the site of p53 and p21 induction. DNA strand breaks, but not apoptosis
were observed in small airway epithelium following irradiation. Clara cells, isolated
from wild type and p53-deficient mice, were 5 Gray y-irradiated from the same
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radiation source and monitored for behavioural changes by Time-Lapse
Videomicroscopy, and cell cycle changes by BrdU incorporation. Apoptosis was not
observed in videos of either genotype. DNA-damage induced growth arrest, not
demonstrable in vivo due to the low turnover of small airway epithelium, was
observed in primary cultured Clara cells and was p53-dependent.
The author reports that Bax induction, but not apoptosis, is a DNA damage response
of small airway epithelium of mice. Transactivation of Bax was p53-dependent in
irradiated lung, as determined by RNase protection, with a twofold increase in Bax
mRNA occurring in the lungs of wild type mice from 4-8 hours following irradiation.
The observed p53 response is reminiscent of the in vivo radiation response of the
murine small intestine, whereby a wave of apoptosis is observed in intestinal
epithelial cells of wild type, but not p53-/- mice, within 4 hours following irradiation
(Clarke et ah, 1994). Bax induction is a feature of irradiated enterocytes and
associates with apoptosis, as determined by morphological criteria (Kitada et ah,
1996). TUNEL positive cells were observed in airway epithelium following DNA
damage, but did not display the morphological features associated with apoptosis.
Furthermore, TUNEL reactions were easily titratable in irradiated cells of wild type
lung, but not the spleen where TUNEL positive cells additionally displayed the
hallmarks of apoptosis including nuclear condensation and collapse of the nucleus.
Consequently, it is unlikely that TUNEL staining in lung epithelium reflects the
oligonucleosomal DNA fragmentation characteristic of lymphoid cell apoptosis. It is
probable that the TUNEL reaction additionally recognises DNA strand breaks
induced by ionizing radiation. In this respect, it is noteworthy that similar
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observations have been reported previously in lung epithelium following insidious
oxidative damage induced by bleomycin and hyperoxia (Okudela et ah, 1999;
Barrazone etal., 1997).
Transrepression of Bcl-xs was additionally observed in irradiated lungs, and was
c
p53-dependent, as determined by RNase Protection Assay. Bcl-x is a potent
promoter of apoptosis when overexpressed in cultured cells, but can be inhibited by
co-expression of either Bcl-2 or the Bcl-x long isoform (Tao et ah, 1998;
Lindenboim et ah, 2000). A physiological role of Bcl-x in promoting apoptosis has
been difficult to assess experimentally due to the native pre-mRNA being shared by
sboth the long and short isoforms. However, induction of endogenous Bcl-x has
been achieved through the control of Bcl-x pre-mRNA splicing by antisense
oligonucleotides (Taylor et ah, 1999), and correlates with the induction of apoptosis
in certain cell lines (e.g. MCF7 cells, Simoes-Wust et ah, 2000). p53-null mice do
not display the rapid transrepression of Bcl-x observed in wild type lungs, as
determined by measuring relative mRNA abundance, but rather display a modest
. c
(>50%) increase in levels of Bcl-x transcripts. It is unclear if this reflects a direct
role of p53 in alternative splicing. An alternative possibility is that Bcl-xs induction
in p53-/- animals represents a compensatory function of an as yet undescribed DNA
damage/oxidative injury response pathway in airway epithelial cells which serves to
regulate the Bcl-2 family rheostat in the absence of p53. In this respect, it is
noteworthy that both Bax and Bcl-x proteins colocalise to the same subset of lung
epithelial cells of the mouse - the bronchiolar epithelium - consistent with
overlapping functions in vivo. The Bcl-x long isoform, renowned for its death-
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suppressor activity in other mouse tissues (Chao & Korsmeyer, 1997; Xu et al.,
1999; Pena et al., 1998; Parsadanian et al., 1998), was constitutively expressed in
small airway epithelium, as determined by SDS-PAGE analysis, and may represent
one mechanism by which irradiated lung epithelial cells maintain resistance to
apoptosis despite induction of pro-apoptotic Bcl-2 family members. Recently,
induction of Bax and Bcl-xL mRNAs have been reported in mouse lungs following
exposure to 95% oxygen, and the authors argue that Bax and Bcl-xL induction is a
feature of ROS-damaged lungs (O'Reilly et al., 2000). The authors used an identical
RNase Protection Assay kit to the one used in this analysis (mAPO-2, Pharmingen),
and report induction of Bax and Bcl-xL mRNAs in hyperoxic lungs from the earliest
time point considered of 48 hours. By contrast, the results of this thesis, whereby
little change in Bcl-xL mRNA is observed in mouse lungs following y-radiation,
argue against Bcl-xL induction as a general feature of oxidative injury, and instead
invoke that there are qualitative differences between radiation- and hyperoxia-
induced lung injuries. The underlying mechanisms by which these two oxidative
injuries may differ have yet to be resolved, but the trans-regulatory effects reported
here and elsewhere (O'Reilly et al., 2000) highlight the suitability of RNase
Protection Assays in detecting changes in gene expression in mouse models of acute
lung injury, and could be used to further address subtle differences between varying
types of inhalational/oxidative injury (e.g. NO2, SO2, tobacco smoke).
To investigate the effects of p53 in proliferating airway cells, a method for isolating
and culturing Clara cells, a progenitor cell of the lung, was incorporated into this
research. A major finding of this analysis was that primary cultured Clara cells,
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deficient in p53, displayed spontaneous multinucleation and the formation of bilobed
nuclei, and that these nucleation abnormalities correlated with disturbances in
centrosome homeostasis. Centrosomes ensure spindle polarity and thus correct
chromosome segregation during mitosis (Hyman, 1996), and their assembly is tightly
controlled with the cell cycle (Figure 4.1; for recent review, see Tarapore &
Fukasawa, 2000). Because each daughter cell receives only one centrosome after
mitotic division, the centrosome must duplicate during the mitotic cycle of the
daughter cell. In considering the similarities between wild type and p53-/- Clara cell
baseline proliferation rate, it would appear that in p53-/- cultures, centrosomes
undergo multiple cycles of duplication in a single cell cycle. Similar observations
have been reported in p53-/- murine embryonic fibroblasts (Fukasawa et ah, 1996),
whereby multiple copies of centrosomes are generated from early in Gl. The
adverse consequence of multiple centrosomes is most prominently seen in mitosis as
multipolar spindles, a feature of p53-/- Clara cell cultures as documented by time-
lapse videomicroscopy (for video, see appendix). Such events are likely to impair
chromosomal segregation and induce karyotypic instability and mitosis by failure to
form bipolar mitotic spindles (Figure 4.2). However, it is noteworthy that an
abnormal centrosome number does not necessarily induce mitotic abnormalities, and
that multiple copies of centrosomes may instead co-migrate to the poles, establishing
bipolar spindles and normal chromosome segregation - a phenomenon known as
pseudobipolarity (Tarapore & Fukasawa, 2000; see Figure 3.1.x, anaphase).
Consequently, only a proportion of p53-deficient cells with an abnormal centrosome
number would be expected to display an abnormal chromosome content.
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Centrosome
Figure 4.1 - The Centrosome Duplication Cycle. Centrosome duplication occurs
once during each cell cycle, and is tightly coordinated with DNA replication. In
wild type cells, centrosome duplication begins in late G1 and is completed in G2.
Loss of centrosome duplication cycle regulation or uncoupling of the centrosome
duplication cycle from the DNA replication cycle leads to abnormal amplification
of centrosomes, which in turn profoundly affects mitotic fidelity.
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Figure 4.2 - Two possible mechanisms by which multinucleation of p53 -/- Clara
cells is achieved based on Time-Lapse Videomicroscopy and centrosome data.
Fig. a) depicts multinucleation without loss of chromsomes. Fig. b) illustrates
the formation of multinucleated cells with abnormal chromosome content
(aneuploid).
138
Effects of DNA damage were additionally characterised in primary cultures of Clara
cells. The author documents that growth arrest, but not apoptosis, is a Clara cell
response to ionizing radiation, and is p53-dependent. However, the Clara cell
radiation response was additionally dependent on extracellular factors - specifically,
the addition of serum to the medium was sufficient to abolish the p53-induced
growth arrest. Effects of extracellular factors on the p53 response have likewise
been observed in primary cultured murine hepatocytes (Bellamy et ah, 1997a) and
human lung cancer cell lines (Kannan et al., 2000), and highlight modulatory effects
the tissue microenvironment may impose upon the p53 response in vivo. It should be
emphasised that it is currently unclear to what degree cytokines and other growth
factors expressed in injured lung (including Oncostatin M, Interleukin-8, Interleukin-
ip, TNF-a, TGF-Pi) augment epithelial wound repair and/or the p53 response,
especially in the context of the centriacinar damage typical of human emphysema.
Suffice to say, interspecies differences in design of the airways, in the number and
nature (e.g. P450 isoenzyme expression) of the various epithelial cell types has
rendered centriacinar emphysema relatively resistant to modelling in experimental
animals. In the latter respect, it is possible that the primary culture method described
in this analysis could be used to distinguish the relative importance of growth factors
and cytokines in influencing Clara cell behaviour from a genetic standpoint, and thus
provide one method of determining the mechanisms underlying the bronchiolar
remodelling typical of human emphysema.
139
4.2. p53 and Cancer of the Small Airways
p53 is frequently mutated in lung adenocarcinoma (Bennett et al., 1999), but the
mechanism by which p53 deficiency contributes to malignancy is not defined.
Various studies suggest that adenocarcinomas of the peripheral lung, like many other
cancers, develop by multiple steps from atypical adenomatous hyperplasia through
early in situ carcinoma to overt carcinoma (Kitamura et ah, 1995; Kitamura et ah,
1996; Anami et ah, 1998). Mutation of p53 is an early event in the tumourigenesis of
lung adenocarcinoma, and is often observed in hyperplastic lesions. In one study,
overexpression of p53 protein, a reflection of missense mutations of the p53 DNA-
binding domain locus, correlated with the Ki-67 labeling index and thus proliferation
of hyperplastic cells (Hayashi et ah, 1997). It is thus conceivable that p53 deficiency
confers a proliferative advantage in hyperplastic lesions. In this analysis, the author
reports that p53 regulates a growth arrest response in proliferating airway cells. The
growth arrest response was characterised in primary cultured Clara cells in response
to DNA damage, and was further dependent on extracellular factors, such as serum.
However, p53 status did not alter baseline proliferation rates, which were similar
between genotypes. Thus, loss of p53 per se does not confer a proliferative
advantage in mitotically dividing airway cells. It is possible that the hyperplastic
microenvironment is a p53-activating environment, and that the growth arrest
response is a formidable selective pressure that a tumour must overcome, for
example, in response to insidious oxidative species, such as those released by
inflammatory cells, or from exposure to hypoxia, an in vivo consequence of
disorganised neovascularisation of the tumour mass (Lakin & Jackson, 1999; Brown,
2000). However, it is additionally possible that p53 suppresses tumour formation by
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mechanisms distinct from growth arrest. In the latter respect, a role of p53 in
maintaining mitotic fidelity was observed in primary cultured Clara cells.
Specifically, nucleation defects were apparent in p53-deficient cells, and correlated
with centrosome amplification and resultant spindle abnormalities. Chromosomal
instability is a feature of advancing lung tumourigenesis and the observed defects in
centrosome homeostasis may underline one mechanism by which this is achieved.
Notwithstanding this, centrosome amplification has been reported in a variety of
human malignancies, including primary lung tumours and lung tumour metastatses
(Pihan et ah, 1998). It is currently unclear which of the observed functions of p53
predominates as the major tumour suppressor mechanism of the small airways. An
attractive, alternative possibility is that the properties reported herein reflect the
central role of p53 in maintaining genomic integrity via multiple mechanisms, and
highlight the multi-functional nature of tumour suppressor p53.
In summary, effects of p53 deficiency were characterised in small airway epithelium
in vivo, and in short-term primary cultures of isolated Clara cells. p53 stabilisation
was a feature of DNA-damaged lung epithelium, and was associated with
transactivation of the death-related gene Bax and trans-repression of Bcl-xs, as
determined by RNase Protection Assay. Radiation did not induce apoptosis in lung
epithelial cells over a 72 hour time course, but did induce strand breaks that were
detectable by TUNEL. Cell cycle activity was infrequent in lung epithelial cells at
all timepoints, regardless of p53 status, thus an effect of p53 on cell cycle
progression was not demonstrable in vivo. To investigate the effects of p53 in
proliferating airway cells, a method for extracting, isolating, and culturing Clara
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cells, a progenitor cell of the lung, was incorporated into this analysis. Proliferating
Clara cells displayed DNA damage-induced growth arrest, which was p53-
dependent, but not apoptosis. Defects in mitosis and cytokinesis were an additional
feature of p53-deficient cells, irrespective of radiation injury, and were associated
with disturbances in centrosome homeostasis. The author suggests that tumour
suppressor properties of p53 in lung epithelium reflect its central tenet in preserving
genomic integrity via multiple mechanisms, of which some are reported here. The
author additionally wishes to highlight the importance of murine Clara cell primary
culture as a powerful method for determining the functional significance of gene
deficiency in airway epithelium.
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4.3. Conditional Gene Targeting in Small Airway Epithelium
In addition, this thesis examined the feasibility of using a SP-C/Cre transgene to
achieve conditional gene targeting in lung epithelial cells in vivo. Transgenic mice
engineered to express Cre from the lung-specific promoter human SP-C were crossed
to a Floxed DNA Ligase I line, and transgene stability and function assessed by PCR
and Southern blot methodologies. Excision of the floxed allele was infrequent in the
lungs of transgenic mice, and was not observed by a Southern analysis strategy that
quantified the relative abundance of floxed, wild type, and excised DNA Ligase I
alleles. RT-PCR strategies were further employed to address the question of Cre
expression in SP-C/Cre transgenic mice. Cre expression was not detected in the
lungs of SP-C/Cre transgenic mice, consistent with a failure to transcribe Cre in vivo.
Failure to transcribe Cre may reflect 1) the low copy number of the SP-C/Cre
transgene concatemer, 2) position effects relating to the site of transgene integration,
or 3) methylational inactivation of the SP-C/Cre transgene established during the
generation the C57/BL6 founder line. These three possibilities are not necessarily
mutually exclusive, and all have the potential to induce heritable transcriptional
silencing of the SP-C/Cre transgene.
Ligases are necessary for phosphodiester bond formation - the final step in repair of
strand breaks. Strand breaks may be introduced directly by a DNA-damaging agent,
such as ionizing radiation, or as a consequence of DNA repair proteins recognising
and excising DNA damage. DNA-joining events are additionally required to link
together the Okazaki fragments generated during lagging strand DNA synthesis. In
prokaryotes, DNA-joining requirements are fulfilled by a single species of DNA
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ligase. Consequently, DNA ligase mutants exhibit a pleiotropic phenotype that
includes conditional lethality, hyperrecombination, increased sensitivity to DNA-
damaging agents, and an increased mutation frequency (Lehman, 1974). By contrast,
eukaryotes contain multiple species of DNA ligase with distinct, non-overlapping
roles. DNA Ligase I represents the majority of the DNA ligase activity in
proliferating cells, which may reflect a direct role of this gene product in DNA
replication. Notwithstanding this, a specific requirement for DNA Ligase I to
reconstitute lagging strand DNA synthesis has been demonstrated in vitro. Purified
DNA Ligase I was necessary for repair of Okazaki fragments in reconstituting
complete SV40 DNA replication with purified replication factors (Waga et al.,
1994). Ligase I activity was demonstrated by biochemical criteria - specifically, 32P-
oligo(dT)/poly(dA) ligation in cell-free extracts. DNA Ligase III did not substitute
for DNA Ligase I in repair of Okazaki fragments in this assay, highlighting substrate
specificity of the ligation reaction. Failure to repair Okazaki fragments efficiently is
considered integral to the haematopoietic failure and consequent embryonic lethality
of DNA Ligase I-deficient mice (Bentley et al., 1996).
Direct evidence of a role of DNA Ligase I in DNA repair is from the study of a
human, a DNA Ligase I compond heterozygote, who has become known to the
scientific world as patient 46BR (reviewed in Friedberg et al., 1995). The individual
from whom these cells were derived was a girl who manifested a complex clinical
syndrome of dwarfism, the absence of secondary sexual characteristics, dilated
venous capillaries, and severe photosensitivity. The patient also had severe
immunodeficiency, characterised by a deficiency in IgA and IgG, and a failure of her
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lymphocytes to respond to mitogenic stimuli in vitro. The patient suffered recurrent
infections and died at the age of 19, apparently as a result of chronic lymphoma and
an acute respiratory infection. No definitive diagnosis of the patient's disease was
made; hence, this clinical picture has no formal designation. It is estimated that
patient 46BR possessed less than 10% ligase I activity (Friedberg et al., 1995). A
cell line derived from this patient demonstrated defective joining of Okazaki
fragments during semiconservative DNA synthesis. In addition, the 46BR cell line
was found to be markedly sensitive to killing by a variety of DNA-damaging agents,
including UV radiation, y radiation, and a number of alkylating agents. More
recently, Comet assay analysis of 46BR cells, compared to two Bloom's syndrome
cell lines, revealed a specific role of DNA Ligase I in repair of UV-induced damage,
but not y-irradiation induced injury (Nocentini, 1995). 46BR cells exhibited a
marked DNA re-ligation defect after ultraviolet radiation damage. These
observations highlight a role of DNA Ligase I in Nucleotide Excision Repair.
It should be emphasised that the Floxed DNA Ligase I cassette utilised in this
analysis was used primarily as an investigative tool, a marker of SP-C/Cre-mediated
recombination in the lungs of transgenic mice, and has been used previously to
characterise BLG-Cre-mediated excision in mouse mammary epithelium (Selbert et
al, 1998). Regardless, it is tempting to speculate as to the phenotype of the Floxed
DNA Ligase I mice if the SP-C/Cre transgene had provided adequate levels of
excision. For example, Cre-mediated deletion of DNA Ligase I in lung epithelial
cells may render mice sensitive to killing by agents damaging to 46BR cells.
Alternatively, deletion of Floxed DNA ligase I from a SP-C/Cre recombinase may
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induce developmental abnormalities/perinatal lethality due to dysmorphogenesis of
the developing lung buds, a feasible consequence of defective Okazaki fragment
repair in embryonic tissues. In considering effects of acute lung injury relevant to
this thesis, it is additionally noteworthy that mice conditionally deficient in Bcl-x
using the Cre-lox system have recently been reported (Wagner et ah, 2000).
Conditional deletion of the Bcl-x gene was demonstrated in erythroid cells using a
MMTV-LTR driven Cre, and highlight the effects of Bcl-x deficiency on cell
proliferation, maturation, and survival in this cell type. Both the Bcl-x long and short
isoforms are expressed in murine lung epithelial cells (see sections 3.1.a, 3.1.b),
however their functions are unclear. It is possible that Bcl-x regulates life/death
decisions in the developing lung comparable to what is observed during
erythropoiesis. It is additionally possible that Bcl-x modulates the radiation response
in adult lung epithelial cells, favouring survival over apoptosis and counteracting the
effects of proapoptotic Bcl-2 family genes, such as Bax (see section 3.1.b).
Discerning the role of Bcl-x in mouse lung epithelial cells would be a project
particularly amenable to investigation using SP-C/Cre mice.
In conclusion, the SP-C/Cre mouse line reported in this thesis is unlikely to be useful
in generating improved mouse models of acute lung injury. In theory, conditional
ablation of a floxed gene of interest would be used to infer the significance of a
gene/genetic pathway in toxic responses of the airways. The excised DNA Ligase I
allele, when observed, was detected only by PCR and correspondingly is likely to
reflect the sensitivity of PCR methodologies in detecting infrequent excision events
in the lungs of SP-C/Cre transgenic mice. However, it is possible that the mouse line
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reported herein may be of use in determining the effects of gene deficiency in other
contexts e.g. malignancy, whereby loss of heterozygousity in but a tiny fraction of
cells may nevertheless induce phenotypic change and pathological consequence in an
in vivo environment. In this respect, it is noteworthy that Floxed Rb mice have been
engineered and characterised (Marino et al., 2000), and present themselve as a
promising line of future study, especially if crossed onto a p53 null background (by
analogy with SP-C/SV40 T antigen mice, Wikenheiser et al., 1992; see Marino et al.,
2000). With regards to developing a tool that dissects the roles of candidate genes in
the context of acute lung injury, the current SP-C/Cre mouse line is clearly
inadequate; however, the possibility remains that with the creation of more founder
mice, a few may display higher i.e. detectable levels of Cre expression and the
capacity for Cre-mediated recombination when bred onto a floxed background. As
an improvement on the current SP-C/Cre strategy, whereby transgene expression
analysis is accomplished post-mortem, the author suggests coinjecting the SP-C/Cre
construct with an easily identifiable transgene, such as luciferase (as illustrated in
Figure 4.3). This strategy has been used to successfully identify expression levels of
the pituitary-specific POM-C/Cre transgene non-invasively in live mice, facilitating















Figure 4.3. A noninvasive method of detecting Cre expression in vivo. Cre
and luciferase transgenes intergate at a single site when coinjected into
oocyte pronuclei. Founder mice expressing luciferase are detected by
luciferin injection immediately prior to image analysis with a charged couple
device (CCD) camera. Methodology based on that used to characterise the
pituitary-specific POM-C/Cre transgene (Lyons et al., in press).
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5. Appendix
5.1. Time-lapse videomicroscopy of p53-/- Clara cells
Isolated p53 null Clara cells were seeded to chamber flasks and subjected to time-
lapse videomicroscopy for a period of 24 hours (from 24 to 48 hours in culture).
p53-/- Clara cells displayed an array of mitosis and cytokinesis abnormalities,
including multiple spindle formation and multinucleation.
Videos of p53-/- cells are available on CD-ROM and are attached to the inner leaf of
this thesis. Videos are stored in a Flash (swf) format, and can be accessed with
Flash, QuickTime, Netscape, or Internet Explorer.
5.2. Bcl-2 family Ribonuclease Protection Assays
Complete data sets for Bax, Bcl-xL, and Bcl-xs mRNA expression, as determined by
RNase Protection Assay relative to housekeeping L32 mRNA, are presented in table






































































































































































































380g Acrylamide (Kodak 5521)
20g N,N-Methylene-bisacrylamide (Kodak 8383)
Dissolve in approx. 800ml of deionised water and adjust to a final volume of 1L with
deionised water (store at 4°C).
lOx Agarose gel loading dye
1.5g Ficoll (Sigma F-2637)
0.02g Bromophenol blue (Sigma B-0126)
0.02g xylene cyanole FF (Kodak T-1579)
dHiO to 10ml (store at -20°C).
Alkaline lysis solution (NaOH/SDS)
20ml 1 N NaOH
10ml 10% SDS
dH20 to 100ml (make fresh)






15 % Ammonium persulfate (APS)
1.5g APS
dH20 to 10ml (store at 4°C).
Ampicillin (Amp)
0.5g Ampicillin (Sigma A-9518)
dFI20 to 100ml (Add to media for final cone. 100 pg/ml)
10X denaturing buffer
2ml 1 M Tris-HCl, pH 9.5
20pi 0.5MEDTA, pH 8.0
lml 100 mM spermidine
dH20 to 10ml (aliquot and store at -20°C)
DNase-free RNase A
200mg RNase A (Sigma R-5500)
3.3pl 3 M NaOAc, pH 4.5
dH20 to 10ml
boil for 10 minutes (aliquot and store at -20°C).
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0.5 M EDTA, pH 8.0 (disodium ethylenediamine tetraacetate)
186.lg Na2EDTA
Dissolve in approx. 400ml dH20, adjust pH to 8.0 with 10 N NaOH, and adjust to 1
litre final volume with distilled water.
100 mM EDTA
20ml 0.5 M EDTA
80ml dH20
5mg/ml ethidium bromide (EtBr)
500mg EtBr (Sigma E-8751)
dH20 to 100ml
1 M HEPES, pH 7.5
23.83g HEPES (Sigma H-3375)
dH20 to 100ml
adjust pH to 7.5 with potassium hydroxide (KOH) (store at 4°C).




7.5pM each of dGTP, dCTP, dTTP
LB Medium
lOg Bacto-Tryptone (Difco 0123-01-1)
5g Bacto-yeast extract (Difco 0127-05-3)
lOg NaCl "
dH20 to 1 L
adjust the pH to 7.0 and then autoclave to sterilize
LB plates
lOg Bacto-Tryptone (Difco 0123-01-1)
5g Bacto-yeast extract (Difco 0127-05-3)
lOg NaCl
15g Bacto-agar (Difco 0140-01)
dH20 to 1 L
autoclave to sterilize, cool to 55°C, add antibiotic if desired, and pour into sterile
petri dishes (approx. 20ml/plate).
lOx Ligation buffer
5ml 1 M Tris-HCl, pH 7.6
lml 1 M MgCl2
lml 1 M DTT
lml 100 mM ATP
2.5mg BSA
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Stored at room temperature
1 M MgCb (magnesium chloride)
20.33g MgCl2-6H20
dH20 to 100ml
1 M MgS04 (magnesium sulfate)
12.04g MgS04




1 volumes glacial acetic acid
1 M MOPS
20.93g MOPS (Sigma M-1254)
Dissolve in 80ml dH20, adjust pH to 7.5 with 1 N NaOH, and bring volume to
100ml.
10X MOPS buffer
400ml 1 M MOPS, pH 7.5
170ml 3 M NaCl
100ml 1 M MgC12
330ml dH20
20 mM dNTP stocks:
80pl 100 mM dNTP
40pi 50:1 TE buffer
280pl dH20
Neutralisation/Solution P3
3.0M potassium acetate, pH 5.5











5ml 1 M KC1




250pl 100 mM dATP
250pl 100 mM dCTP
250pl 100 mM dGTP
250pl 100 mM dTTP
11.5ml dH20
Aliquot this into 25 tubes with 500pl in each tube.
Phenol, TE-saturated
Add an equal volume of 10 mM Tris-HCl, pH 7.5-8.0, 1 mM Na2EDTA to ultrapure
phenol, mix well, allow phases to separate, remove and discard upper (aqueous)





Buffer QBT (Equilibration buffer)
750mM NaCl
50mM MOPS, pH 7.0
15% isopropanol
0.15% Triton® X-100
Buffer QC (wash buffer)
1.0M NaCl
50mM MOPS, pH 7.0
15% isopropanol
Buffer QF (Elution buffer)
1.25M NaCl




50mM Tris-HCl, pH 8.0
lOmM EDTA
lOOpg/ml RNase A












Sequencing Gel Solution (for RNase Protection Assay)
250g Urea
75ml 19:1, 40% acrylamide solution
50ml lOxTBE
175ml dH20
For each gel 60ml of the above solution was mixed with 60pl of TEMED and 60pl
of fresh 25% ammonium persulphate (in dH20) and immediately poured.
SOC Media
2% w/v Tryptone
0.5% w/v Yeast Extract
0.05% NaCl
Autoclave and add the following filter sterilised reagents. 1% (v/v) 1M MgCl2j 1%
(v/v) 1M MgS04 and 0.1% (v/v) 2M glucose solution.
2M NaOAc (sodium acetate)
27.22g NaOAc-3H20
dH20 to 100ml
3M NaOAc, pH 4.5
408.24g Na0Ac-3H20
Dissolve in approx. 800ml dH20, adjust pH to 4.5 with glacial acetic acid and bring
to a final volume of 1 L with dH20.
3M NaCl (sodium chloride)
17.53g NaCl
dH20 to 100ml




10ml 10 N NaOH
dH20 to 100ml
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10% SDS (sodium dodecyl sulfate)
lOg SDS (Fisher S529-3)
dH20 to 100ml
20X SSC (standard saline-citrate)
17.53g NaCl
8.82g sodium citrate
Dissolve in approx. 80ml dH20, adjust pH to 7.0 with HC1 and bring final volume to
100ml.
IX SSC (standard saline-citrate)
5ml 20X SSC
95ml dH20










Dissolve in approx. 700ml of deionised water, adjust the pH to 8.3 with glacial acetic










make up to 4L with dH20, pH to 7.4 with HC1





make up to 4L with dH20, pH to 7.4 with HC1
add 12.5ml Tween-20
make up to 5L
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TEMED (N,N,N' ,N' -tetramethylethylenediamine)
Severn 20-3000-01, store protected from light at 15°C.
TE (10:1) buffer
10ml 1 M Tris-HCl, pH 7.6
2ml 0.5 M EDTA
dH20 to 1 L
1M Tris-HCl, pH 7.6, 8.0, 8.5, 9.0, 9.5
121.lg Tris base
dH20 to 800ml
Adjust pH with concentrated HC1 and then add dH20 to 1 L.
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7.1. To my Lunchtime Brethren...
for those moments of wisdom we shared between the first and second course. We would have
been rich with that glow-in-the-dark jellyfish idea, if it wasn't for Alan's failure to cooperate
(more on him later). As Senior Fellows of the United Transgenic Collective, and co-founders of
the Artery, Retina, Sphincter and Epididymis Group (A.R.S.E.), it is only fair to acknowledge you
on your own merits.
7.1.a. Jason -1 know you didn't touch her. And, I know you didn't do anything with the other one
either. No, I don't want any water, thank you. Give up the BAC-cloning strategy, instead adopt a
FUC-cloning strategy. If you ever wish to pack it in, move to Cuba, and do genetic fingerprints of
cigars, my beach hut awaits you. I must additionally remind you that you are contractually obliged
to star in my Kung Fu / Techno / Horror production, due out in the Summer of 2001 (verbal
agreement, Black Bo's, 6lh-7th pint)...so don't go trying to leave the country on me now.
7.1.b. Dom - Raised in the swamps, and nurtured in the ways of the wild, the Mastery of this Man
in the field of Southern Blotting was at one time legendary. It is said of this man that he was
fuelled by a unique combination of philosophy, spirituality, and toxins from the night previous.
He has now turned to the Dark Side of the Force, and can speak CC++ fluently, but has yet
maintained his culinary values. I fear we have not heard the last of this one...
7.1.c. Jon - You are a danger to yourself and to others in the lab, and the sheer concept of giving
you a PhD is ludicrous. You are nevertheless the solid backbone of our Teviot Campaign and, as
resident postdoc, should be lending your academic weight to the finer matters of science, such as
the possibility of an espresso machine in the office. Hedonism and pursuit of pleasure have never
been so singularly personified, and one fears for the influence this one may have on any future
nubile PhD students. Our theses will stand as Testaments to the Great God Dionysus, as
monuments to those halcyon days at the latter part of the 20lh Century.
7.2. To Eleanor, Jan, Tracey, and Liz 'the Legs' Lovejoy...
for introducing me to how filthy girls could be. I have never heard such debilitating smut in my
entire life. The gynaecological depravities you openly discuss over mid-morning coffee breaks
will haunt me to the grave. You have filthy mouths and filthy minds.
p.s. Cheer up Natters, you'll get a mention in your own good time. Got lots to say about you.
7.3. To Alan...
for enlightening me on the ways of reptilia. I have no idea why you asked "What's this got to do
with lizards?" at that CRC meeting, nor do I know why you are so prejudiced against jellyfish.
The legacy of the Man with the Moustache and his love of frothy ales are like a solvent breath onto
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the very walls of Teviot Laboratories. Your uncompromsing ability to catch tawdry students
crawling in late, combined with your capacity to drive in a way as to stabilise p53 (Armit,
unpublished observation) render you a legend in your own time. Its been a pleasure working with
you, Alan, and, yes, I'd love to work with you again. Not right now, you understand, but
sometime real soon...
7.4. To David...
for lending us that fifty quid at Christmas, and for entertaining my appreciation of the cosmos in
its entirety. You've convinced me that lungs are not but tedious bags of poorly developed
glandular tissue, bastard sons of an endoderm ancestry as ancient as the metazoa, but as an area of
research requiring further study. Tales of nurturing sickly Clara cells and of RNase Protection will
be told to my Grandchildren, once a year, at Halloween. Regardless, your uncomprising capacity
to behave like a not very serious man at all lends itself a gratitude that knows no bounds. I thank
you for finding the cash, the time, and the effort required in getting a shabby individual like myself
a PhD.
7.5. To my fellow scientists...
so much to say, so little time. No, seriously, I've got several hours to get this bastard in or they're
gonna fine me £450. But that's bureacracy for you. There's a cockerel crowing (or whatever it is
that cockerels do) suggesting that its almost Dawn. Either that or we've got a very confused
cockerel on our hands...Difficult to say...Do cockerels crow?...Surely, its crows that crow...
Clearly I've been awake too long. Having slept a wink in 72 hours. But that's another story.
Shirley, cheers for all the help through the years, for your ability to smile and tolerate my
tantrums. We shared the pain of your Cre mouse. I wish you and Connor a happy life together...
Sharon, fashion guru and winner of the Most Irish Girl In Scotland award, your ability to eat
banana sandwiches for breakfast, lunch and dinner astounds me. You are a vision with your
doorstopper bread, a slab of cheese, and the omnipotent Cart-O-Death, and I wish you well in
whatever you decide to do...
Andrea and Clare, alright, you're not from the Pathology lab anymore, but you're a logical
progression from oor Shazza. I would acknowledge you both independently, but as you've been
living together for quite some time, I feel it acceptable to refer to you in the collective. For the
Glastonbury mud, the music enthusiasm, and those boozy nights in Manga I commend you both.
You can work for me anytime...
Owen, for tales of lightning strikes, wellies, and dead dogs.. .Kim, for being blonde...
7.6. To Scotty, Andy, and Dunes, for fine wines, a shared love of hammocks, a brace of Kwak's,
and the inevitable Mr.Green. Viva Haarlemmermeerstraat, viva Las Vegas...
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7.7. To Natters, don't you weep
All your stationery still looks
neat










7.8. To Catherine, for putting up with me and my year long pilgrimages to strange and faraway
places...
7.9. To all the future students...
who will enrage Teviot's weathered walls; God spare thee the mania and the madness associated
with molecular mechanisms. I would advise against any form of 'novel' technology, and refrain
from using the word 'timepoint', but alas I fear that you will be culturing toenail epithelium and
manipulating nipple hair genes in no time. You thus condemn yourselves to a life of intellectual
buggery, and may God have mercy on your souls.
This work was supported by the Salvesen Emphysema Trust. Special thanks to my
supervisors Professor D.J. Harrison & Professor A.R. Clarke for doing a fine job.
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